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ABSTRACT 
 
Cochlear implantation makes hearing restoration possible in patients with severe to profound 
hearing loss. However, patients with residual hearing, where a cochlear implant may be 
combined with acoustic stimulation, and children with malformed cochleae, where the surgery 
itself as well as language training may be a challenge, are two important groups of patients that 
require special procedures. These patient groups are the subject of this thesis.  
The first study (paper I) examined the effects of cochlear implantation on residual hearing and 
postoperative histology in a guinea pig model. After mild to moderate levels of surgical trauma, 
effectuated as a cochleostomy alone or in combination with limited electrode array insertion, 
hearing recovered after a two-week period of loss (a temporary threshold shift). The 
intracochlear structures remained unchanged. A second study (paper II) was performed to test 
the hypothesis that cochlear implantation may induce endolymphatic hydrops, which could 
lead to hearing loss. The results indicate that hydrops is present during the first week after 
cochlear implantation.  
These experimental studies conclude that the guinea pig cochlea shows high resilience to 
cochlear implantation and that mechanical damage incurred during surgery does not explain 
the loss of residual hearing often seen in patients. Secondary mechanisms, such as hydrops, are 
likely to be involved in the early postoperative period. This information is important as patients 
with useful residual hearing increasingly receive cochlear implants. 
Two clinical studies examined the effects of cochlear implant surgery on children with x-linked 
inner ear malformation. The first of these (paper III) describes surgical techniques necessary 
for safe cochlear implantation, and further shows that implantation permits hearing restoration 
and the development of spoken language in these children. Further analysis of hearing and 
language outcomes, cognition and mental health (paper IV) revealed poorer outcome in 
hearing, language and mental health and lower executive functional level, as compared to a 
control group. Genetic analysis confirmed mutations in the POU3F4 gene on the X-
chromosome.  
X-linked malformation deafness is usually considered non-syndromic. However, paper IV 
shows that these children exhibit signs of neuro-developmental problems consistent with 
attention deficit and hyperactivity, which is likely related to the POU3F4 mutation. Hence, x-
linked cochlear malformation should be re-classified as a syndromic form of hearing loss. 
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INTRODUCTION 
 
The cochlear implant replaces a non-functioning inner ear. This invention has revolutionized 
the possibility of hearing rehabilitation for patients with severe to profound deafness. During 
the last decades hundreds of thousands of patients have had the opportunity to hear through 
electrical stimulation of the auditory nerve mediated by the implant. Children born deaf are 
today, to a very large extent, able to learn to hear, speak and attend mainstream schools, and 
children or adults who have turned deaf have the possibility to return to a life with functional 
hearing. The cochlear implant has without doubt changed our view on deafness and opened a 
new field of treatment. 
I remember my first encounter with a patient at first switch-on of a sound processor a couple 
of weeks after cochlear implant surgery. After having been deaf for twenty years she could, 
from one moment to the other, hear when someone spoke to her, and even talk to her relatives 
on the phone! I was truly amazed, and realized that this was something I absolutely had to learn 
more about.  
In spite of the good results for many patients, there are challenges remaining. This thesis 
describes two particular patient groups with special difficulties relating to their cochlear 
implant treatment. The first of these two relate to understanding the mechanisms of hearing 
loss after surgery to the inner ear. Patients with useful residual hearing may, if the hearing is 
preserved at surgery, combine electrical stimulation with acoustic “normal” hearing with 
benefit. However, the patient may lose this possibility as the surgery sometimes induce hearing 
loss, rapid or slowly progressive. The two first papers report on this topic. They are 
experimental with the aim of understanding possible actions relating to loss of hearing during 
cochlear implant surgery.  
The second group with specific challenges are children born deaf because of inner ear 
malformations. The difficulties displayed in this subgroup of pediatric cochlear implant 
recipients include both surgical and post-operative training aspects. This thesis address children 
with x-linked malformation of the inner ear. The last two papers are clinical, describing the 
surgical method and outcome of cochlear implantation, aiming to give a comprehensive picture 
for this group of children. 
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BACKGROUND 
 
THE EAR AND NORMAL HEARING 
In humans, the ear is the organ to register pressure fluctuations within a frequency range we 
call “sound”. The perception of sound requires a functioning hearing organ and auditory neural 
pathways. In addition, to make the sound meaningful, the brain has to interpret the nerve signal 
for the individual to understand what it means. Thus, we are born with the anatomy to listen, 
but we learn to hear. 
Sound, to humans, are vibrations within the frequency range of 20-16000 Hz transmitted 
through a medium, usually air in our everyday life. In an ear with normal function the 
vibrations, propagated as sound pressure alterations, “waves”, reaches the pinna and external 
auditory canal, resulting in movement of the tympanic membrane. These movements are 
transmitted to the inner ear by the ossicular chain located in the air-filled middle ear. The fluid-
filled inner ear contains the sensory epithelium for both hearing and balance. Because the fluid 
is non-compliant the vibrations are routed towards the hearing organ, the cochlea, as the 
mechanical impulses there may be equalized by round window movements. As there is 
normally no such alternative opening in the balance system all sound energy may be picked up 
by the hearing organ (Figure 1).  
The inner ear, capsula otica, is firmly embedded in the very hard petrosal part of the temporal 
bone. The spiral shaped bony labyrinth is filled with perilymph with the membranous labyrinth, 
winding inside, containing endolymph. Inside of the cochlea the fluid compartments are 
divided by the basilar membrane and Reissner’s membrane. In cross section, this gives three 
separate canals, “scalae”, with the hearing organ, the organ of Corti, being located on the basilar 
membrane with its sensory epithelium, the hair cells, facing the endolymphatic space, the scala 
media. With specific mechanical properties, changing along its length, the anatomy of the 
basilar membrane constitutes the base for the separation of frequencies, the tonotopy, of the 
cochlea. A specific frequency of sound will produce a travelling wave along the membrane and 
the physical properties at a certain point of the membrane will be susceptible for those 
frequency vibrations creating a wave maximum. The basilar membrane is stiffer in the basal 
turn corresponding to higher frequencies, and broader, thinner, and less stiff towards the apex, 
creating a wave maximum for lower frequencies. The hair cells in the region of a vibrating 
basilar membrane will react as the stereocilia, attached to the tectorial membrane, will bend 
and activate depolarization (Fridberger et al., 2006), initiating an action potential in the dendrite 
of the spiral ganglion neuron (SGN) propagating as a nerve signal in the axon. Multiple axons 
constitute the auditory nerve running in the internal auditory canal, entering the posterior fossa 
of the skull base and attaching to the brain stem, there connecting to the cochlear nucleus 
(Ulfendahl, 1997, Robles et al., 2001). 
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Figure 1) Cross section of the anatomy of the human ear. The cochlea is colored blue. The third bone 
in the ossicular chain, the stapes, is seen attaching to the inner ear by the oval window. Adjacent to that, 
the round window is seen as a dark hole in the basal turn of the cochlea. Figure printed with permission 
from Cochlear Ltd © 2016 
 
The hair cells of the cochlea are arranged in three rows of outer hair cells (OHC) and a single 
row of inner hair cells (IHC). The human ear can detect a sound pressure of 20 µPa in its most 
sensible area, around 2000-4000 Hz (Gelfand, 2004). This area corresponds well to most of the 
sounds in human speech. (Obviously, as our sense of hearing and our speaking organ, the 
vocals cords and the upper respiratory tract, have evolved together.) The lowest detectible true 
intensity of sound, measured in decibel (dB) Sound pressure level (SPL), varies widely over 
the frequency range.  
Most mammals have the same principal organization of the inner ear, however with large 
variations in sensitivity to frequency range and sound pressure. In this thesis the inner ear of 
the guinea pig has served as a model for experimental studies. The guinea pig is a common 
animal model in auditory research, because much of its hearing range overlaps with the human 
range. Furthermore, the cochlea is relatively accessible in the guinea pig, which facilitates 
experiments. 
HEARING LOSS 
Hearing loss is a very common disorder, in Sweden and worldwide. In Sweden it is today 
approximated that 13% of the population has a hearing loss and half of them to an extent where 
they need hearing aids. Approximately 0.15% of the population is completely deaf. In all, this 
makes hearing loss one of the most common disabilities among the population of Sweden. 
Inability to hear may be related to three different principle problems or a combination of these. 
Conductive hearing loss means there is something wrong with the mechanical portion of the 
hearing, the pathway of the sound from the outer ear through the middle ear. Sensory hearing 
loss relates to malfunction in the cochlea and neural hearing loss to problems in the auditory 
nerves and central auditory pathways. The last two reasons are often described as 
sensorineural. A hearing loss may also be mixed with a combination of conductive and 
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sensorineural components. In addition, the term central hearing loss may be used for processes 
of poor cerebral processing of the sound. The hearing loss may be single-sided or bilateral. 
The average normal sensitivity to sound has been set to a nominal 0dB Hearing level (HL) and 
a hearing loss as additional intensity necessary above that level to detect a sound. 0-20 dB HL 
is regarded a normal hearing. The grading of hearing loss is mild (20-40 dB HL), moderate 
(40-65 dB HL), severe (65-90 dB HL) and profound (>90 dB HL). When describing a hearing 
loss it may be called, for example, “moderate-severe” as it may be moderate in the lower 
frequencies and severe in the higher. To average the loss, a pure tone average (PTA) of the 
frequencies 500, 1000, 2000 and 4000 is often calculated. Cochlear implant candidates in 
general have a bilateral severe-profound sensorineural hearing loss with a PTA over 80dB as a 
majority of the hair cells of the cochlea are absent or non-functioning. Acoustic amplification 
is thereby not an option. However, the spiral ganglion neurons located in the modiolus (in a 
cochlea with normal anatomy) are present and susceptible to electrical stimulation. 
This thesis discusses one specific type of hearing loss, partial deafness, and one specific reason 
for hearing loss, a genetic inner ear malformation called x-linked deafness. 
Partial deafness 
With age all humans gradually lose some of the ability to hear the very highest frequencies, 10-
16 kHz. Such high frequency loss has little effect on everyday life communication as the 
frequencies of the sounds in normal speech and everyday life are located in the region of 125-
8000 Hz. 
The term “partial deafness” relates to a type of hearing loss where the cochlea has little or no 
function in one part and a relatively good function in another. Usually these patients present 
with severe-profound hearing loss in the frequencies above 500-1000 Hz and close to normal 
hearing at frequencies lower than that (Figure 2). Speech perception is very limited, as these 
patients are unable to detect much of the higher speech frequencies, the area of the consonants 
responsible for much of the discrimination of words. Amplification with conventional hearing 
aids offers very limited help as the non-functioning areas of the cochlea have little or no 
remaining hair cells. The patients are regarded difficult to rehabilitate as acoustic stimulations 
is not an option in the frequency areas where amplification is necessary. The majority of partial 
deafness patients are adults where the partial hearing loss has occurred after childhood, and 
they thereby have normal speech. Some cases are congenital or with early onset and these 
children develop an affected speech, related to limited consonant recognition. To evaluate the 
level of hearing loss in patients with partial deafness a PTA of the lower frequencies in the 
audiogram, 125, 250 and 500 Hz, is used for average (PTAlow). 
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Figure 2) Pure tone audiogram of a patient with partial deafness. The hearing thresholds are normal in 
the 125-500 Hz region and very high in the middle- and high frequency region. Red circle- right ear, 
Blue cross- left ear. (PTAlow; right ear 15 dB, left ear 18 dB) 
 
Genetic hearing loss 
Approximately 2/1000 children are born with severe-profound hearing loss and in the 
developed world more than 50% of prelingual deafness has a genetic base. The genetic forms 
of hearing loss may, in addition to otologic examination and audiometry, be suspected by a 
family history with many affected members. A pedigree may reveal a hereditary pattern and 
the traits are traditionally divided into autosomal dominant or recessive, x-linked or 
mitochondrial. The hearing loss may be an isolated symptom or part of a syndrome with 
additional defects. The most common forms of genetic hearing loss are autosomal recessive 
and non-syndromic. Today molecular testing for genetic disease is increasingly common and a 
large number of mutations in genes responsible for hearing loss are known. 
Hereditary hearing loss is most often sensorineural as the genetic anomaly in general affects 
the function of the sensory epithelium, the hair cells, but may be mixed or conductive if a 
simultaneous or isolated malformation of the middle or outer ear is present. Most genetic 
hearing loss is present at birth (prelingual) but may be progressive or with late onset once the 
child has learned to talk (postlingual). Although non-syndromic hearing impairment is more 
common than syndromic, more than 400 genetic syndromes that include hearing loss have been 
described (Toriello et al., 2004). 
X-linked deafness is rare (1-5%), compared to the vast majority of autosomal deafness. It may 
be syndromic, as in Alport or Mohr-Tranebjerg syndrome, but the majority of X-linked hearing 
loss is non-syndromic. Examples of the latter are DFNX1-DFNX4 (Petersen et al., 2008), and 
the most common of these (50%) is DFNX2 that gives a congenital, progressive mixed severe-
profound hearing loss (Figure 3).  
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Figure 3) Preoperative air- and bone behavioral hearing thresholds as a function of frequency (visual 
reinforcement audiometry) in children with x-linked deafness (paper III and IV). Mean and SEM for 
each frequency. 
 
On imaging of the temporal bone a typical malformation of the inner ear is seen (Gong et al., 
2014) classified as Incomplete Partition, type 3 (IP3) (Sennaroglu et al., 2006). DFNX2 is the 
only form of x-linked hearing loss to give a bony malformation of the inner ear. In DFNX2 
mutations in the gene POU3F4 were identified already in 1995 by de Kok and co-workers (de 
Kok et al., 1995). Naturally, most children with symptoms from a mutation in a gene on the X-
chromosome are boys, and accordingly the majority of patients with DFNX2 are male. The 
role of POU3F4 (POU domain, class 3, transcription factor 4 (Brain-4)) is to encode a 
transcription factor which has a role in cellular regulation by binding to DNA, controlling the 
coding of genetic information from DNA to RNA. POU3F4 is part of a larger group of genes, 
the POU domain genes, controlling early development, however, the specific regulatory role 
of POU3F4 is not fully clarified. It is described to have a function during very early stages of 
embryogenesis, linked to the development of the neural tube (neuroepithelial cells) (Choi et 
al., 2013) and is found in the forebrain, including the supraoptic and paraventricular nuclei of 
the hypothalamus in rat studies (Mathis et al., 1992). It is also found to be expressed in the 
periotic bone (later capsula otica) and the fibrocytes of the cochlear duct (Phippard et al., 1998). 
It is thought to have a role in cell signaling during labyrinthine development necessary for spiral 
ganglion innervation. Animal studies on pou3f4 gene knock-out mice have revealed bony inner 
ear (Phippard et al., 1998) and spiral ligament (Minowa et al., 1999) deformities. The later may 
affect potassium ion homeostasis. In humans, an increasing number of POU3F4 mutations are 
reported. These include intragenic missense or frameshift mutations but also deletions in the 
gene or in the upstream regulatory element. 
COCHLEAR MALFORMATIONS 
The normal shaped cochlea has a well-defined bony modiolus harboring the spiral ganglion 
neurons and the afferent axons of the beginning of the auditory nerve. The nerve passes a bony 
cribriform plate at the fundus separating the cochlea from the internal auditory canal, and 
thereby acts as a border for the intracranial cerebrospinal fluid (CSF) and the perilymphatic 
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space inside of the cochlea. The internal structure is well-organized in three separate canals, 
“scala”, as described above, scala vestibuli, scala media and scala tympani. 
Deviations from the normal anatomy are referred to as malformations. The inner ear develops 
in gestation week three to eight and disturbances during this period will result in an abnormal 
anatomy. In some cases, there is a clear genetic cause to the malformation but in others it is 
unclear why the inner ear is malformed and the hearing loss may be the only symptom. Hearing 
loss related to a malformation is always congenital but may in some cases be mild at birth and 
progress during life. 
Diagnosis and classification depends on reliable imaging, high resolution CT and MRI. 
Limitations to computed tomography include soft tissues as they are poorly visualized as 
opacities only. The CT examination gives answer to size, the intracochlear lumen, the modiolus 
and the bony parts of the partitions inside of the lumen. 3 Tesla MRI adds substantial soft tissue 
information but resolution is still limited regarding intracochlear fibrous and neural structures. 
Nonetheless, the results of imaging today allow a more differentiated classification. 
Classifications 
In 1791 Carl Mondini first described a deformity of the inner ear (Mondini, 1791). Cochlear 
malformations are sometimes still inappropriately described as a “Mondini malformation” 
regardless type of abnormality. In 1987 Jackler and co-workers suggested a classification 
(Jackler et al., 1987) introducing divisions of the cochlear malformations common cavity, 
incomplete partition and hypoplasia. In addition, there are two rare, severe deformities of the 
temporal bone, Michel deformity and cochlear aplasia where, in both cases, the cochlea is 
absent. Sennaroğlu and Saatci proposed a more precise classification in 2002 (Sennaroglu et 
al., 2002),where the incomplete partition group is further subclassified.  
In the Sennaroğlu classification a cochlea with incomplete partition (IP) has a relatively normal 
size of its external borders and there are three subgroups, type 1 with a cystic cochlea and a 
severe modiolar dysplasia, type 2 with a defined basal turn but a bud-shaped apex and a 
moderate modiolar dysplasia and type 3 with a cork screw appearance of the cochlea, modiolar 
aplasia, absent cribriform bone in the fundus and a wide internal auditory canal. In addition 
hypoplastic cochleae are grouped in type 1-3, with type 1 being the most severe. The 
Sennaroğlu classification is today widely accepted and will be used in this thesis. 
IP 1 is often referred to as a cystic cochlea-vestibular malformation, type 2 is the classic 
Mondini malformation and coexists with a large vestibular aqueduct and type 3 is related to a 
mutation in the POU3F4 gene on the X-chromosome. Paper III and IV investigates a group of 
children with POU3F4 related deafness and subsequently, in this thesis, incomplete partition 
type 3 is discussed more in detail.  
As mentioned above children with x-linked malformation are born with a mixed hearing loss, 
often rapidly progressing to a severe-profound level. As their hearing loss is identified on 
neonatal screening and auditory brainstem response (ABR) they may be deemed as suitable for 
a cochlear implant and referred for imaging of the temporal bone. As the imaging, starting with 
an MRI and, in cases of anomaly, followed by a CT, reveals a malformation the diagnosis is 
clear but may be additionally confirmed with genetic testing.  
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On imaging of the temporal bone a typical malformation of the inner ear is seen (Figure 4) 
(Gong et al., 2014), classified as Incomplete Partition, type 3 (IP3) (Sennaroglu et al., 2006). 
  
  
Figure 4) X-linked malformation of the inner ear. Axial CT image demonstrating a cystic malformation 
with modiolar aplasia (left image) and 3D-reconstruction of an MRI (right image) with the 
perilymphatic space colored white demonstrating an abnormal cork screw appearance of the cochlea 
and a very wide internal auditory canal (IAC). Courtesy of Babak Falahat, DDS, Karolinska University 
Hospital 
 
In recent years all pediatric cochlear implant recipients with a cochlear malformation has been 
assessed, implanted and followed at Karolinska University Hospital in Stockholm. This has 
opened a unique opportunity for a comprehensive overall approach to this subgroup of patients. 
COCHLEAR IMPLANTS 
A cochlear implant is an electric device which turns sound into electrical impulses. It consists 
of an external part, the sound processor, and internal implant, the receiver-stimulator and the 
electrode array. In principle the sound is picked up by microphones on the sound processor and 
is after processing sent through the skin as a frequency modulation (FM)-signal to the implant 
by an antenna behind the ear (Figure 5). The coil of the implant picks up the signal and converts 
it into electrical impulses sent out in an array positioned in the cochlea (Clark, 2006). The sound 
frequencies are divided into channels, 12, 16 or 22 depending on the manufacturer, and each 
channel is lead to a specific electrode on the array, thus separating the intracochlear electrical 
stimulation according to tonotopy. The electrodes stimulate the neurons of the spiral ganglion 
in the modiolus with electrical currents according to the frequencies in the envelope of the 
sound (Wilson et al., 1991). 
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Figure 5) Cross section of a cochlear implant. The sound processor and external antenna is seen behind 
the ear. A transparent image of the receiver-stimulator is noticed under the hair and the electrode array 
is out lined trough the bone and middle ear and entering the cochlea. Figure printed with permission from 
MED-EL © 2016 
 
There are several electrode array options of for implantation. Electrodes with a prefixed 
curvature give a perimodiolar positioning inside the cochlea whereas straight electrodes remain 
along the lateral wall of the scala tympani. The electrodes also have alternative lengths, 20-31 
mm, depending on if a deep insertion is attempted or not. Short electrodes, around 20 mm, have 
been used in cases of residual hearing in the low frequencies aiming at hearing preservation.  
Cochlear implants may be used uni- or bilaterally. In unilateral cases it may be combined with 
a conventional hearing aid on the other ear if this is experienced as a benefit by the patient. 
COCHLEAR IMPLANTATION SURGERY 
Cochlear implantation in patients is a standardized procedure in general anesthesia. A 
postauricular incision and transmastoid approach including a posterior tympanotomy is the 
most common access to the middle ear and the basal turn of the cochlea, the promontory. The 
opening to the scala tympani can be performed by drilling a hole in the promontory, a 
cochleostomy, or by incising the round window membrane. The electrode array of the cochlear 
implant may thereby be inserted into the cochlea following the anatomical boundaries of the 
scala tympani. Soft tissues are used to pack for sealing around the electrode. The receiver-
stimulator package is positioned on the cranium in a subperiosteal pocket followed by wound 
closure in multiple layers. Intraoperative electrophysiological testing confirms the implant 
integrity and neural response of the auditory pathway. Postoperative x-ray verifies a correct 
positioning of the electrode inside the cochlea. The patient is given one dose of intravenous 
antibiotics.  
Surgery and residual hearing 
In the case of a patient with residual hearing, as for patients with partial deafness as described 
above, the aim during surgery is to preserve the remaining auditory function. This allows the 
use of acoustic amplification and electrical stimulation in the same ear. The concept of “soft 
surgery” to the cochlea was developed by Lehnhardt (Lehnhardt, 1993) and in 1999 von Ilberg 
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described the possibility of combined electrical and acoustic, bimodal, stimulation (EAS®) in 
the same ear (von Ilberg C, 1999). This type of hybrid hearing requires a postoperative result 
of better than 80 dB HL in the frequencies of amplification, often 125, 250 and 500 Hz, for a 
useful residual hearing. The concept today includes meticulous care not to touch the ossicular 
chain, careful exposure of the round window membrane or endosteum of the scala tympani, the 
use of local application of cortisone in the middle ear, incision of the round window membrane 
or endosteum and slow insertion of the electrode array. Postoperative steroids are administered 
for one week.  
It is well described that patients with partial deafness benefit from a CI alone compared to 
preoperative use of a hearing aid (Cullen et al., 2004, Dowell et al., 2004). This is important as 
not all patients preserve their residual hearing. In a review of cochlear implantation in patients 
with residual hearing Talbot and Hartley concluded that 13% of the recipients sustain a total 
loss of residual hearing and 24% > 20dB. (Talbot et al., 2008). In recent years, clinical studies 
evaluated long-term outcomes of cochlear implantation in patients with residual hearing. 
Mertens et al. (Mertens et al., 2014) described a group of 9 patients (11 ears), followed for 10 
years, showing complete low-frequency hearing preservation in 27%, partial preservation in 
45%, minimal in 18% and loss of residual hearing in one subject. This study used the 
HEARRING group Hearing Preservation Classification System (0% = loss of hearing; >0%-
25% = minimal HP; >25%-75% = partial HP; >75% = complete HP) (Skarzynski et al., 2013) 
to evaluate hearing preservation rates and compare results of different strategies of intervention. 
Helbig and co-workers analyzed 103 ears (96 patients) up to eleven years after implantation 
(Helbig et al., 2016). 12 month results (n=81) showed 31% complete hearing preservation, 
48% partial and 13% minimal. Eight percent exhibited total loss of residual hearing. In a ten-
year follow-up (n=62) 27% had complete preservation, 39% partial and 15% minimal. In 
patients with total hearing loss, no association was seen to etiology or surgical approach. In this 
study PTAlow shifts ≤10 dB are regarded as complete preservation, between 10 and 30 dB as 
partial and ≥30 dB as minimal. Regarding auditory outcome, several authors showed that with 
preserved hearing, a combined stimulation is of benefit to the auditory outcome (Lorens et al., 
2008, Gstoettner et al., 2009, Gifford et al., 2013). These postoperative studies examine hearing 
with the CI alone, HA alone and in combination with bimodal stimulation in one ear.  
The loss of residual hearing in the early or late postoperative period continues to be a problem 
in spite refinement of surgical technique (Skarzynski et al., 2007), electrode designs (Wanna 
et al., 2014) and use of intraoperative drugs (Ye et al., 2007, James et al., 2008, Connolly et 
al., 2011). The underlying intracochlear mechanisms remain unclear. The surgical trauma, 
including the insertion of the electrode, may induce direct mechanical damage and activate 
inflammatory or cell death pathways (Eshraghi et al., 2006). The presence of an electrode in 
scala tympani also cause fibrosis (O'Leary et al., 2013). This, in combination with the electrode 
volume itself, is likely to generate an “intracochlear” conductive hearing loss. Paper I and II in 
this thesis investigates patterns of loss of residual hearing after cochlear implantation (I) and a 
possible mechanism responsible for alterations in hearing (II). 
Surgery in malformed cochleae 
Due to the variant anatomy of the malformed cochlea, a cochlear implantation may constitute 
a challenge. There are several aspects to consider. These cases are almost always pediatric with 
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the special needs related to that, especially as these children may have additional handicaps. In 
rare cases cranio-facial or upper airway malformations are present and anesthesia has to be 
planned accordingly. Abnormalities, other than the inner ear malformation, may co-exist in the 
temporal bone, the most important being a deviant facial nerve route or aberrant veins, making 
the approach challenging. The cochlea itself may be opened by the RW or a cochleostomy 
depending on visualization. The choice of electrode depends on the size of the cochlea, the type 
of malformation, and whether cerebrospinal fluid (CSF) gusher is present. The latter 
necessitates meticulous sealing around the electrode. All severe malformations require 
intraoperative x-ray to confirm the electrode position. 
SPEECH, LANGUAGE, COGNITION AND MENTAL HEALTH 
The ability to hear is necessary for speech development. Without early stimulation of the 
auditory system, the brain loses the ability to analyze and interpret signals from the auditory 
nerve. During the first years of pediatric cochlear implantation, the age of implantation was 
often four or five years and, although the children did learn to hear, their speech and language 
development was limited (Nicholas et al., 2007). With adoption of earlier implantation age, the 
hearing results have become increasingly better and results today often include excellent open 
set speech recognition. Today, as a general rule, the spoken language of children with a 
cochlear implant is often at the level of age-equivalent peers in terms of intelligibility, 
vocabulary and fluency and many attend mainstream schools (Dettman et al., 2016).  However, 
it is important to remember that these children still suffer from hearing impairment making 
listening difficult, especially in noisy situations. Also, there are subgroups with special needs 
or handicaps requiring additional support and special schools. Furthermore, some children are 
still operated late due to immigration, adoption or similar reasons and multiple languages used 
in a family also make spoken language development more difficult (Teschendorf et al., 2011).  
The clinical experience of meeting children with x-linked malformation is that this group 
exhibit special features, including hyperactivity and attention problems. Children with hearing 
loss may display a similar picture. However, the x-linked group, seen in clinic at follow-up, 
resemble each other with a behavior different from most other pediatric CI recipients. 
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AIMS 
 
 
 
This thesis considers two different aspects of cochlear implantation. The first two papers, I and 
II, are experimental and address the problem of hearing preservation in patients with residual 
hearing who receive a cochlear implant. To investigate this, a guinea pig model for cochlear 
implantation was used. The second aspect of the thesis relates to cochlear implantation in 
malformed cochleae. Paper III and IV are clinical studies investigating a group of children with 
severe-profound hearing loss related to x-linked malformation. These studies explore their 
treatment with cochlear implantation and if they require special attention during surgery and 
follow-up. 
 
 
Paper I. The aim was to study the effects of different levels of trauma during cochlear 
implantation on residual hearing and cochlear histology. 
 
 
Paper II. The hypothesis of this study was that endolymphatic hydrops, induced by cochlear 
implantation, may be responsible for the delayed hearing loss and vertigo seen in some CI 
recipients with residual hearing. The aim was to determine if signs of hydrops were present in 
a guinea pig model after cochlear implantation. 
 
 
Paper III. X-linked malformation is an unusual reason for severe-profound hearing loss in 
children. To date only a few cases have been described in the literature. Treatment with 
cochlear implants has been described as related to risks of complications during surgery and 
the reported outcome doubtful. The purpose of this study was to describe a surgical method, 
evaluate complications and determine hearing outcomes with cochlear implants. 
 
 
Paper IV. This paper in depth investigates the language outcome, cognitive abilities and 
mental health in a group of children with x-linked malformation compared to a control group. 
Their POU3F4 gene mutation is analyzed with the hypothesis of this being a syndromic hearing 
loss.  
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METHODS 
 
SURGICAL PROCEDURES 
Guinea Pigs (Papers I and II) 
In the experimental set-up for papers I and II adult Duncan-Hartley guinea pigs were used, 
albino in paper I and tricolor in paper II. The animals were housed at the animal departments 
of Karolinska University Hospital (paper I) and the Royal Victorian Eye and Ear Hospital 
(paper II) respectively. The experiments were performed in accordance with ethical standards 
of the Animal Care Committee in Stockholm, Sweden (paper I, Ethics approval: N12/10) and 
the Animal Research Ethics Committee, Melbourne, Australia (Paper II, Ethics approval: 
12/261AR). The animals were anaesthetized with ketamine 40mg/kg and xylazine 10mg/kg 
(paper I) or ketamine 60 mg/kg and xylazine 4 mg/kg (paper II) given as intramuscular 
injections. The same anesthesia was used during surgeries as during later hearing testing. 
In cochlear implantation in a guinea pig, the bulla is exposed with a postauricular incision. The 
bone of the bulla was removed with a knife or a burr (bullostomy). A cochleostomy was drilled 
on the promontory to open the scala tympani and an electrode array inserted. Soft tissue was 
applied around the electrode to seal the opening. The wound was closed with resorbable sutures 
and the animals received an intraperitoneal injection with 0.2 ml buprenorphine 0.3 mg/ml, a 
subdermal injection of 5 ml Saline 0.9% subcutaneously and 1 ml doxycykline (2 mg/ml). 
 
          
Figure 6) Guinea pig cochlear implant electrode. In this figure the model used in Group 3 in paper I is 
shown in a). The implant is seen in b) after cochlear implantation through a cochleostomy adjacent to 
the RW. 
 
In the current papers, the dummy electrode lacked metallic stimulation electrodes, as the 
hypothesis was related to the insertion and presence of the electrode itself and not to electrical 
stimulation (Figure 6). This was also preferred as metal artefacts may disturb micro-CT 
imaging (paper II). The array was fixed inside the bulla and remained there during the entire 
study period, also after dissecting out the cohlea. In paper I it was made of polyethylene tubing 
and silicone and in paper II of a flexible and elastic silicone polymer. 
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Patients (Papers III and IV) 
The studies in paper III and IV involve ten children with x-linked malformation resulting in 
inner ear malformation (Incomplete Partition type 3, IP 3). Their hearing loss was discovered 
at neonatal hearing screening in nine cases and after attempts at early hearing aid fitting, they 
were referred to the Cochlear Implant Clinic at the ENT Department at the Karolinska 
University Hospital. Further examination with temporal bone imaging and genetics revealed a 
POU3F4 mutation explaining their mixed severe-profound hearing loss. They were deemed 
suitable for a cochlear implantation, and the mean age at first implant was 1.8 years (range=0.9-
2.8 years). Five of these children received a second implant in a sequential procedure, and the 
others use a hearing aid on the contralateral ear. 
As described above, this particular malformation includes severe modiolar dysplasia and the 
cribriform bone in the fundus of the cochlea is absent. This leads to an open communication to 
the internal auditory canal (IAC) and the cerebrospinal fluid (CSF) space. Opening to the 
intracochlear space results in a gusher of CSF that lasts for approximately 15 minutes. The 
properties of this specific malformation requires special procedures. First, intraoperative x-ray 
is used to confirm that the electrode array is positioned inside the cochlea and not displaced 
into the IAC. Second, the opening in the cochlea must be firmly sealed to avoid postoperative 
rhinorrhea. The surgical procedure developed at Karolinska University Hospital includes RW 
insertion and the use of a straight electrode array. It is described in detail in paper III.  
In paper IV the study subjects with x-linked malformation were compared with a control group. 
The control group were children with Connexin 26 mutations resulting in deafness; they were 
recruited from a larger group of tested children and matched for gender, age and use of cochlear 
implants.  
AUDIOLOGY 
Objective Measures (Papers I and II) 
Electrophysiological measurements allow hearing thresholds to be determined in patients or 
study animals without active participation of the subject. In the techniques described below, 
the electrical response from intracochlear potential or nerve impulses generated by multiple 
short sounds are recorded and averaged. This results in a graph with time on the x-axis and 
electrical potential on the y-axis. The sounds presented can be multi-frequency clicks, testing 
the whole organ of Corti, or a pure tone, testing the cochlear region corresponding to that 
frequency. A decreasing sound stimulus level gives a successively reduced electrical response 
and it is thereby possible to identify a threshold. In animal studies the thresholds for different 
frequencies are defined in every individual animal before any intervention. 
Electrocochleography (ECochG) 
Electrocochleography registers the electrical potential created inside the cochlea during sound 
stimulation. It reflects electro-mechanical processes in the organ of Corti and alterations in the 
response may therefore indicate the presence of endolymphatic hydrops (Fridberger et al., 
1997). In paper II, where possible hydrops after cochlear implantation was examined, ECochG 
was used at different time points after surgery (one day, one week, four weeks and three 
months). The anaesthetized animal was placed in a sound proof chamber with reference 
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electrodes on the scalp and hind leg (ground). After a postauricular incision and bullostomy, a 
gold ball recording electrode was placed in the RW niche. Sound stimuli were 8-ms tone bursts 
at the frequencies 2, 4, 8, 16 and 32 kHz, averaged over 125 stimulus presentations (Figure 7). 
In this study, cochlear implantation followed the first recording and in the final recording the 
bulla was opened but the cochlear implant kept in place. 
 
Figure 7) Example of electrocochleography recording, in this case in animal HH03 one week after 
cochlear implantation. Sound stimulation frequency is 8 kHz. The compound action potential (AP) is 
marked in green and the time period for measuring the summation potential (SP) as red. With increasing 
attenuation of the sound (sound intensity decreasing by 5 dB steps) the AP response decreases. Note the 
change in the response scale bar from 0.1 mV to 0.02 mV to the left (dBA, Decibel Attenuation).  
 
Hearing threshold was defined as the lowest intensity that gave a response, compound action 
potential (CAP) of >0.5 µV. The first negative to the first positive peak indicated the CAP 
amplitude (green in figure 7). The SP was measured at 5.5-6.5 ms following onset of stimulus 
at the relatively stable plateau after the CAP (red in figure 7). A SP/AP ratio was calculated as 
a functional estimate of hydrops. Separately for each stimulus frequency postoperative SP/AP 
ratios were divided by pre-operative SP/AP ratios to quantify the change in the ratio over time. 
This gave an index, here called the “SP/AP ratio change” for each frequency. 
Auditory Brainstem Response (ABR) 
Auditory Brainstem Response (ABR) was used in paper I to evaluate electrophysiological 
hearing thresholds in the guinea pigs. The anaesthetized animal was placed in a sound proof 
box with electrodes attached to the vertex, the postauricular area and the hind hip. The 
loudspeaker was connected to the external auditory canal with a silicone tube. The initial sound 
stimulus was 90 dB peak SPL. A 5 dB reduction of the sound gives a successively reduced 
electrical response and the hearing threshold is estimated to when wave V, corresponding to 
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the synapse of the cochlear nucleus in the brain stem, disappears. The threshold is defined as 
the lowest intensity with a visible wave V in two averaged runs. Six different pure tone 
frequencies were analyzed in this work, 1, 2, 6.3, 12.5, 16 and 20 kHz. A postoperative 
threshold shift is calculated as the difference between the preoperative threshold and the 
measured threshold at different time points after surgery. I paper I these were immediately after 
insertion (0), day one (1), day four (4), one week (7), two weeks (14) and four weeks (28). 
Psychoacoustic Methods (Papers III and IV) 
Methods to determine hearing in subjects often depends on a response or interaction where the 
subject indicates that he or she has heard something, in adults and older children by pressing a 
button. These methods are called psychoacoustic. The tests are performed in sound-proofed 
rooms with low ambient sound level and short reverberation time. 
Pure tone Audiometry 
The most common way to test hearing is pure tone audiometry, which we often refer to as a 
“hearing test”. This indicates a level of detection of sound at different frequencies. In the 
present studies, when the children were too young to interact by pressing a button to indicate 
when they hear, their responses were determined by observing their reactions to sound 
(behavioral observation audiometry) (Karikoski et al., 1998)) or with visual reinforcement 
audiometry, (Shaw et al., 2004). This pediatric audiometry requires an experienced child 
audiologist. In paper III and IV, children were tested with the sound presented by loudspeakers, 
in “free field” conditions (not with headphones). A crucial advantage of free field testing is that 
it allows hearing aids or cochlear implants to be used. Children between 2.5 and 5 usually are 
tested with conditioned play audiometry (Dawson et al., 1998). 
Speech Audiometry 
Speech audiometry allows assessment of the level of word discrimination. Testing how 
subjects actually experience the words presented, by repeating what they just heard, permits 
better evaluation of how well their hearing works in everyday life. Words are composed by 
multiple frequencies, vowels and consonants, and word discrimination therefore requires a 
relatively well functioning cochlea, as well as central auditory pathways. This is referred to as 
speech recognition. In paper III and IV the children were tested with monosyllabic 
phonemically balanced word lists (Haskins, 1949, Liden, 1954). The results are presented as a 
percentage correct. The test was performed in quiet with the words presented at 65 dB SPL 
from a loud speaker in front of the child and in noise with the same speech signal but disturbed 
by a noise signal from four separated loud speakers (+/- 45-135 degrees azimuth). The signal-
to-noise ratio was fixed at 0 dB. The mean age of the children tested in the x-linked group was 
7.8 years (range=9.8-5.6, n=6). In the control group in paper IV the children had a mean age of 
7.2 years (range=4.5-12.7, n=5). Children younger than four years cannot be tested with speech 
audiometry. The speech testing was performed with cochlear implants and/or hearing aids. 
Localization of sound 
Sound localization along the horizontal dimension requires two functioning ears. The ability to 
localize sounds is important, since it also facilitates the understanding of speech in noisy 
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situations (Hawley et al., 2004). As binaural hearing is the aim in most children with severe-
profound hearing loss, with cochlear implants or in combination by a CI and a hearing aid, they 
may develop spatial hearing. However, in spite of binaural stimulation, sound localization 
accuracy remains poorer in children with CI (Lovett et al., 2010, Asp et al., 2015). In paper III 
and IV, children were presented to sound from five loud speakers in a semi-circle separated by 
45 degrees (spanning 180 degrees). The measurement consisted of 10 sound stimuli presented 
in random order from any of the loud speakers, and children were instructed to point at the loud 
speaker that generated the sound (Asp et al., 2011). All tested children had binaural hearing, 
either with two cochlear implants or a cochlear implant in one ear combined with a hearing aid 
on the other ear (bimodal). 
MORPHOLOGY (PAPERS I AND II) 
After final electrophysiological measurements, the cochleae of the guinea pigs were prepared 
for histological analysis. The animals were euthanized with a pentobarbital sodium injection 
(25 mg/kg intraperitoneal) and either decapitated directly (paper I) or transcardially perfused 
with 0.9% saline followed by 10% neutral buffered formalin (paper II). 
Surface Preparation 
The cochleae were removed from the temporal bone and the perilymphatic space was perfused 
with 4% paraformaldehyde. The bony outer wall of the cochlea, the stria vascularis, Reissner´s 
membrane and the tectorial membrane were removed with forceps and the exposed organ of 
Corti was stained with Phalloidin to enhance the actin in the stereocilia of the hair cells. 
Following this, the basilar membrane was dissected from the osseous spiral ligament in half-
turns and mounted on a microscope glass slide. The hair cells were examined in a fluorescence 
microscope (Zeiss) and missing inner or outer hair cells were counted, apex to base (Figure 8). 
The organ of Corti is 19 mm long in a guinea pig. Hair cell loss, seen as scar formation of the 
cuticular plate, were presented in place-specific cochleograms representing a percentage loss 
along the organ of Corti. 
 
Figure 8) Picture of the organ of Corti in a guinea pig in a fluorescence microscope after surface 
preparation. The three rows of outer hair cells (OHC) are visible with one scar formation in the middle 
row. (IHC Inner Hair Cells) 
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Spiral ganglion Cell Density (Paper I) 
The cochleae were removed from the temporal bone, trimmed and decalcified in 0.1M 
Ethylene-Diamine-Tetraacetic Acid for two weeks. Following dehydration, they were 
embedded in 2-hydroxyethyl methacrylate plastic (Technovit 7100) attempting an orientation 
for mid-modiolar sectioning. 24 µm cryosections were sliced and mounted on glass slides, 
keeping the electrode array within the cochlea. The nuclei of the spiral ganglion neurons were 
counted with an optical fractionator technique (Gundersen et al., 1988), examining every tenth 
section with a 12 µm deep “optical dissector”. An estimate of the total SGN number within the 
cochlea was calculated (Voie et al., 1993). 
Micro-CT (Paper II) 
After collection of the cochleae, they were prepared for examining with micro-CT. The round 
window was incised, and a small opening near the helicotrema was made to facilitate staining 
of the intracochlear soft tissues with 4% osmium tetroxide. The cochleae were examined with 
an Xradia microXCT-200 scanner, aiming for a mid-modiolar axis of rotation (Figure 9). A 
reconstruction software, TXMReconstructor, was used to reformate a three-dimensional 
volume and, after corrections, slicing this for image analysis (Amira 5.4, Visualization Sciences 
Group, France). The presence of endolymphatic hydrops (EH) was identified by examining the 
position of Reissner’s membrane (RM). The extent was quantified, at the positions along the 
basilar membrane corresponding to the frequencies examined with ECochG (2, 4, 8, 16 and 32 
kHz).  
 
  
 
Figure 9) To the left a non-reformatted micro-CT image of a guinea pig cochlea. The stria vascularis, 
organ of Corti and Reissner´s membrane were visible. To the right a magnification of the basilar 
membrane, scala media and scala tympani. Marked in red is the method of calculating “scala media area 
differences” (SMADs) at each location along the cochlea. The SMAD is the area between the observed 
position of Reissner's membrane and its normal resting position. (SGN Spiral Ganglion Neuron, SV 
Scala Vestibuli, SM Scala Media) 
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Two methods to quantify EH was used. A developed Radiological Hydrops Score (RHS) was 
calculated by initial transmodiolar visual identification of the position of RM in relation to its 
neutral position. The displacement shape of RM was first defined by visual inspection as 
straight (normal), convex (hydropic), concave (“enhydropic”) or flaccid, where RM was longer 
than usual, but its curvature was inconsistent. To arrive at a measure of EH the RHS (value 0-
1) was calculated in every cochlea as the proportion of the RM that showed the convex shape 
typical of EH. For a second measure of EH was the “scala media area difference” (SMAD) was 
calculated (in %). The SMAD is the area between the observed position of RM and its normal 
resting position (Figure 9 right). SMAD was 0 at the normal position of RM. A convex RM, as 
in a hydropic cochlea, resulted in a positive SMAD value whereas a concave RM gave a 
negative value. For a summary measure for each cochlea the values obtained at the different 
positions were averaged.  
The extent of soft tissue around the electrode was calculated by identifying the limits of scala 
tympani followed by coloring of the electrode on every fifth slice, interpolating the intervening 
slices (Matlab). Areas in the scala tympani with higher radio-opacity were identified as soft 
tissue. Several measures were quantified, the total tissue response volume, the tissue response 
volume isolated to each quadrant (defined as upper inner (Q1), upper outer (Q2), lower outer 
(Q3) and lower inner (Q4)) of the scala tympani, the maximum percentage of the cross-
sectional area of scala tympani that was occluded by tissue response or electrode at any point 
along the cochlea, and the amount of tissue response within 200 µm of the organ of Corti.. 
GENETICS (PAPERS III AND IV) 
A blood sample was collected from the participants for DNA extraction. Primary molecular 
testing for mutations in POU3F4 was performed with multiplex ligation-dependent probe 
amplification (MLPA), which is a DNA-based method for detection of deletions and 
duplications (Schouten et al., 2002). The mix of probes included two in the POU3F4 gene as 
well as 4 probes targeting the 1 Mb regulatory region upstream of POU3F4. In addition, probes 
for other common exons involved in hearing loss were included such as all GJB2, GJB6 
(Connexin 26 and 30, DFNB1) and GJB3 exons (Connexin 31) as well as WFS1 (Wolfram 
syndrome) (P163-D1, MRC-Holland).  
In cases were no mutation was found with MLPA, Sanger sequencing of POU3F4 was 
performed in order to detect point mutations in exon one of the gene. 
SPOKEN LANGUAGE, COGNITION AND MENTAL HEALTH (PAPERS III AND 
IV) 
Speech- and language pathologists assessed the speech and spoken language performance of 
each subject. A series of test materials were used aiming to recognize the specific difficulties 
for children with cochlear implants. Paper III focused on speech intelligibility and expressive 
grammar whereas paper IV also included verbal fluency, vocabulary and commutative aspects 
of pragmatic skills (Table 1). For assessment of cognition a psychologist evaluated the children 
with a series of tests and questionnaires focusing on executive functions. Mental health was 
assessed by questionnaires and focus group discussions. 
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Spoken language 
For expressive vocabulary the Swedish version of the Boston Naming Test (BNT) was used. 
Stanine (STAndard NINE, scores following normal distribution divided into nine intervals) 
results are reported in relation to age (Tallberg, 2005). Verbal fluency was assessed by FAS-
test (testing phonemic fluency on the letters F, A, S) and Animal (testing semantic fluency). 
Pragmatics, rules for social language, were evaluated by the Children’s Communication 
Checklist-2 edition (CCC-2) (Bishop, 2003) parental screening questionnaire estimating a 
child’s communication skills. (In addition to pragmatics it assesses the areas of syntax, 
morphology, semantics, and speech.) Different subscores such as General Communication 
Composite score (GCC) or Social Interaction Difference Index (SIDI) may be obtained 
identifying weaknesses in different areas of language. In the area of pragmatics the scores relate 
to nonverbal communication, social relations and interests. To test how comprehensible the 
participants’ speech was the Speech Intelligibility Rating-2 (SIR-2, score 1-5) (Allen et al., 
2001) was used and rating of expressive grammar was done by a speech-language pathologist 
using a locally developed scale (EGS, score 1-9) (Löfkvist, 2014). 
 
Table 1) Tests of spoken language, cognition and mental health used in papers III-IV. 
Measure/Test name Paper III Paper IV 
Spoken language ability    
Expressive vocabulary; The Boston Naming Test (BNT)  
 
Phonemic word fluency task; (FAS)  
Semantic word fluency task; (Animal)  
 
Pragmatic skills; Children’s Communication Checklist-2 edition (CCC-2)  
 
Speech intelligibility; Speech Intelligibility Rating-2 (SIR-2)  
(rating of speech-language pathologist) 
 
Expressive grammar; Expressive Grammar Scale (EGS)  
(rating of speech-language pathologist) 
 
 
 
 
 
 
 
X 
 
 
X 
 
X 
 
X 
X 
 
X 
 
X 
 
 
X 
Cognition and mental health   
Executive functioning: 
Test of Everyday Attention for Children (TEA-Ch)  
 
General Working memory; Sound Information Processing System (SIPS)   
 Phonological Working memory; SIPS 
 
BRIEF-P and BRIEF  
(parent and teacher questionnaire)  
 
 X 
 
 
X 
X 
 
 
X 
Non-verbal cognitive ability (Ravens Colored Progressive Matrices)    X 
Strengths and Difficulties Questionnaire (SDQ)  
(parent and teacher questionnaire) 
X X 
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Cognition 
Evaluation of cognition focused on executive functions. In this sense cognition relates to 
working memory, attentional and inhibitory control, flexibility, as well as reasoning, problem 
solving, and planning. In this study, children older than six years were evaluated by the Test of 
Everyday Attention for Children (TEA-Ch, nine subtests) (Baron, 2001, Heaton, 2012). Their 
general working memory was assessed by the Sound Information Processing System (SIPS), 
the phonological working memory by the subtest Sentence Completion and Recall task (Wass, 
2009). Questionnaires used were  BRIEF (Behavior Rating Inventory of Executive Function, 
parents and teachers) (Isquith et al., 2004) for judging executive functions and Ravens Colored 
Progressive Matrices for measuring abstract reasoning and intelligence (Raven, 2003). 
Mental health 
The mental health status of the children was measured by questionnaires and focus group 
discussions lead by a social worker. The standardized Strength and Difficulties Questionnaire, 
SDQ (Goodman, 1997, Goodman, 2005), was answered by the parents individually and, for 
the children in a school setting, by their teachers. The questionnaire ask about 25 attributes. 
Some of them are positive, others negative. They are divided into five scales consisting of 
emotional symptoms, conduct problems, hyperactivity–inattention, peer problems, and 
prosocial behavior. Each scale has five items scoring 0-2, generating a scale score of 0-10. The 
prosocial behavior scale is inverted compared to the others with lower scores indicates 
difficulties. The four first scales are added to a total difficulty score (0-40). 
STATISTICS 
In paper I and II, analysis of variance of data parameters from ABR or ECochG was performed 
with repeated measures ANOVA (Paper I used the software R for statistical calculations, and 
paper II used SPSS) and validated by Greenhouse-Geissner correction and, as with post-hoc 
testing, least significant difference (LSD) method for multiple comparisons (paper II). 
Descriptive statistics were used to summarize or quantitatively describe features. For non-
parametric comparison of medians analysis, Independent Samples Kruskal-Wallis (multiple 
groups, Paper II) and Mann-Whitney U-test (two groups, paper IV) was used.  
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RESULTS 
 
PAPER I 
Paper I is an experimental study on guinea pigs aiming to investigate cochleostomy and 
insertion trauma at cochlear implantation. This is done by examining alterations in hearing 
thresholds after surgery as well as intracochlear histological changes. Three groups of normal-
hearing guinea pigs underwent cochlear implant surgery. In group 1, only a cochleostomy (C) 
was performed, without insertion of an electrode, in group 2, deep insertion (DI) to a depth of 
4.5 mm was used and in group 3 a “GP modified” insertion to a depth of 3.25 mm was 
performed. 
Residual hearing 
Hearing testing in the groups 1 and 2, followed for 14 days, revealed a statistical difference in 
hearing outcome seen already the first day after surgery (Figure 10). In both groups an 
increased threshold shift is noted after the first week, in group 2 this remains unchanged 
(indicating a permanent hearing loss). In group 1 however, the threshold shift normalizes 
during the second week to a 5-8 dB level on the four frequencies measured. In group 3 
additional testing time points was added at 0, 4 and 28 days. In addition two lower frequencies 
tested were added, 2 and 4 kHz. For the three lower frequencies 2, 4 and 6.3 the pattern of 
threshold shift here shows clear similarities with group 1(C) with hearing loss remaining during 
the first week. On the other hand, the two higher frequencies tested, 16 and 20 kHz, showed 
initial similarities with group 2 (DI) with large initial threshold shift but with the difference of 
rapid decline indicating recovery of auditory function. After two weeks the thresholds had 
stabilized at a level of -1-10 dB remaining unchanged at four weeks. The threshold shifts at 
two weeks are significantly different to group 2 but not to group 1. 
         
Figure 10) Hearing threshold shifts after surgery in guinea pig. Left graph with ABR results after 
cochleostomy alone (C) or deep insertion (DI) in the different frequencies respectively. Bars indicate 
SEM. 
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Histology 
Surface preparation and plastic embedded sectioning was performed in the cochleae of group 
3, five cochleae for each method. Examination showed very limited signs of trauma. Surface 
preparation cochleograms revealed close to no hair cell loss in three examined cochleae and 
40-50% OHC loss in the most apical region (15-19 mm) in two cochleae. Threshold shifts in 
these two animals were not above average for the group. Sectioning revealed histology with 
very limited soft tissue reaction in three of five cochleae and more extensive in the remaining 
two. Hearing results in the corresponding two animals were below average. Spiral ganglion 
neuron (SGN) density did not differ from the result of non-implanted, untreated cochleae. 
 
PAPER II 
In an experimental setup with four groups of normal hearing guinea pigs the hypothesis of 
endolymphatic hydrops induced by cochlear implantation was studied. The four groups were 
followed for 1, 7, 28 or 72 days respectively. 
Electrocochleography 
Measurements were performed prior to surgery, immediately after cochlear implantation and 
at the end of the survival period in each animal. Compound Action Potential (CAP) and 
Summation Potential (SP) was recorded at the frequencies 2, 4, 8, 16 and 32 kHz.  
At the end of the survival period the SP/AP ratio change increased relative to pre-operative 
levels at 1 and 7 days after surgery (Figure 11). This was rarely seen at 28 or 72 days. 
 
                
Figure 11) The summating potential (SP) amplitude plotted against the compound action potential 
(CAP) amplitude in response to a 16 kHz tone, both prior to implantation (solid marker) and at the 
experimental end point (open marker). Each point reflects data in response to one stimulus intensity. A 
and B are examples in two different animals 7 days after CI surgery. As stimulus intensity increases, 
both the SP and the CAP grow in magnitude. At 7 days after CI, the SP grows more rapidly than the 
CAP (as reflected by a steeper growth response), indicating that the SP/AP ratio is greater than pre-
operatively. 
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Alterations in hearing, calculated as CAP threshold shifts comparing results before CI surgery, 
immediately after and at the end of the survival period showed large differences in the 
measured frequencies. The greatest hearing loss was seen in 8 and 16 kHz and immediately 
after implantation. At the end of experiment the loss was largest in the day 1 group with an 
average of 24.7 dB deterioration. The later groups showed less hearing loss, 7 days 6.4 dB, 28 
days 5.2 dB and 72 days 15.6 dB.   
Micro-CT 
All implanted electrodes (21) were located within the scala tympani. There was no sign of 
fracture to the basilar membrane and only one fracture of the osseous spiral lamina. The 
Radiological Hydrops Score (RHS), calculated as an average of the examined cochleae, 
showed a significant hydrops at week 1 but not at day 1 and a tendency of less hydrops at later 
time points as compared to the contralateral ear (Figure 12). The SMAD, averaged across the 
cochlea, was significantly higher at day 1, 7 and 28 after implant surgery than at 72 days. 
 
Figure 12) To the left the Radiological Hydrops Score (RHS) after cochlear implantation as an 
average of hydrops in the four groups of guinea pigs. To the right change in SMAD (scala 
media area difference) in the same groups. 
 
The soft tissue response calculated around the electrode in the basal turn had an average volume 
of 0.93 mm3 representing a median occlusion of the scala tympani of 59% (Figure 13). Most 
of the tissue response was located in the upper outer quadrant (Q2) of scala tympani (51.2%). 
There was only a small non-significant difference in the soft tissue response in the four groups. 
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Figure 13) To the left a micro-CT with electrode array (*) and tissue reaction within scala tympani in 
the basal turn. RM marked white indicating hydrops. Bar equals 150 mm. Right figure is a 
reconstruction of the basal turn. The implanted electrode array is seen in red in the scala tympani. Yellow 
is the organ of Corti and orange tissue response around the electrode. 
 
PAPER III  
In this clinical study a group of ten children, nine boys and one girl, with x-linked malformation 
were evaluated in a retrospective chart review in combination with an assessment day for 
additional auditory and speech and language testing. They had been referred for CI assessment 
and were seen in clinic at an average age of 1.4 years. They all received a first cochlear implant 
at an average age of 1.8 years (range=0.9-2.8 years). Subsequently five received a second 
implant on the opposite ear at average 2.7 years of age (range=2.0-3.8 years). 
Cochlear implantation 
Fifteen implantations have been performed with an average follow-up time of 4.2 years (range 
0.1-8.1 years). All implants were provided by MED-EL®. The electrodes used were straight 
with, in thirteen cases, a length of 24 mm. In one case a 28 mm electrode was used and in 
another a 31 mm electrode. In all cases a gusher was encountered. On insertion the electrode 
deviated into the internal auditory canal in three cases, revealed on intraoperative x-ray (Figure 
14). Access to scala tympani was obtained through the round window in twelve cases and by 
cochleostomy in three. Firm packing around the electrode sealed the opening. In four cases 2-
3 electrodes could not be fully inserted, one of those cases being the 31 mm electrode. One 
case, the first, developed a postoperative rhinorrhea present for six days but ceased on 
conservative treatment.  
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Figure 14) Electrode array seen incorrectly positioned in the IAC where the electrodes on the array are 
highlighted by black dots. 
 
Audiological outcome and communication 
All children have binaural stimulation, five with a contralateral hearing aid. The six oldest 
children were able to perform speech and localization testing. Speech recognition was 
significantly higher in the mean obtained at the national two-center study (nat2) of pediatric CI 
recipients than in the x- linked-group in both quiet and noisy conditions (mean %+/-SD) (x-
linked 48+/-19 versus nat2 87+/-16 in quiet and 24+/-10 versus 61+/-20 in noise). Sound 
localization accuracy was significantly better than chance performance in five of the six tested 
subjects (Error Index 0.36+/-0.14. Four of the tested children had bilateral CIs, the other two 
hearing aids). 
All children use their CIs full time and all have developed spoken language. The three oldest 
use only spoken language whereas the remaining are either bilingual (three of whom two are 
brothers with a deaf father) or use supported signs (the younger children and one child with 
additional cognitive handicap).  
 
PAPER IV 
This paper involves the same ten children as in paper III (x01-x10). These children with 
cochlear implants have shown similarities in their behavior in clinic at follow-up, indicating 
problems beyond their hearing loss. The study therefore focuses on their genetics and outcome 
regarding spoken language, cognition and mental health compared to a control group of 
pediatric CI recipients without cochlear malformation (Connexin 26 (cx 26)). Their mean age 
at last follow-up was 6.0 years (range=2.0-9.7) (cx26 6.6 years, range=1.1-14.6) with a total 
CI follow- up period of 4.2 years (range=1.1-8.1) (cx26 4.7 years, range 0.4-11.1). The mean 
age for first implant was similar in both groups (x-linked 1.1 years (range=0.9-2.8), cx26 1.9 
years (range=0.6-5.5)). A large variability is seen in audiological outcome across groups when 
testing speech in quiet and speech in noise. Speech recognition was significantly higher in the 
cx26-group than in the x- linked-group in both quiet and noisy conditions (mean %+/-SD) (x-
linked 48+/-19 versus cx26 82+/-17 in quiet and 24+/-10 versus 53+/-15 in noise). 
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Genetics 
 
Six of the children (x01, x04, x05, x06, x07 and x10) had previously been involved in genetic 
testing verifying their mutations in the POU3F4 gene and upstream region (Figure 15). 
Additional testing revealed mutations in another three children. One of the children is a girl 
(x07) with a very large deletion in the region of the gene. This child has additional handicaps 
including motor skills and more severe cognition deficits and analysis for x-linked inactivation 
is pending. Two previously undescribed point mutations were found (x08 and x09).   
                    
 
Figure 15) Location of POU3F4 mutations. The green bow represents the POU domain and the blue 
box the POU-specific domain. Horizontal red bars represent minimal region of deletions. Vertical red 
bars indicate the location of the point mutations. Vertical black bars represent the location of the MLPA 
probes. 
 
Spoken language 
The x-linked group scored significantly poorer in expressive vocabulary in the Boston Naming 
Test (BNT, stanine score) between groups (x-linked versus cx 26 z= -2.1, p=0.035) and on raw 
scores (z= -2.31, p=0.021). Pragmatic skills reported from parent questionnaires (CCC-2) 
showed three areas of significant difference with poorer performance in the x-linked group; 
total score (z= 2.41, p=0.015) and on the subscales coherence (z= -2.31, p=0.011) and context 
(z= -2.74, p=0.015). A significant difference was also found for speech intelligibility rating 
(SIR2) (z= -2.30, p<0.014) No significant differences were found between groups in word 
fluency tasks (FAS and Animal) or expressive grammar (EGS). 
Cognition 
Only four children in the x-linked group completed the TEA-Ch test due to fatigue or poor 
concentration. Results revealed a significant difference in only one of the subscales, Spacehunt-
TIME (Z= -2.34, p=0.019). Some group-specific differences were seen with the BRIEF 
parental and teacher report namely, Global Executive Composite of executive functions 
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(parents z= -2.31, p<0.021, teachers z= -2.17, p<0.030) and Behavior Regulation Index 
(parents z=- 2.25, p<0.025, teachers z= -2, 01, p<0.045). On three subscales for parents 
significant differences were found; Emotional control (z=-3.01, p<0.003), Initiate (z=-2.17, 
p<0.030) and working memory (z=-2.08, p<0.038). On the general working memory task 
(Sentence Completion and Recall) the children with x-linked malformation had significantly 
lower scores than controls on the phonological working memory task (Serial recall of non-
sense word-2, z= - 2.08, p<0.037) but not on total scores (p>0.1). However, the group of 
children with x-linked malformation revealed a difference with more semantic irrelevant 
responses. No statistical significant differences were found between groups in Ravens Colored 
Progressive Matrices measuring non-verbal cognitive ability (x- linked vs. cx26) (p’s>0.1). 
Mental Health 
All mothers and almost all fathers of the x-linked group rated the children in a way that 
indicated mental ill-health (x-linked 15.75 vs. cx26 6.2, p<0.001) on the total difficulties score 
(total sum of scales 1-4). Further, parents of children in the x-linked group reported 
significantly higher scores compared to the cx26 group on emotional symptoms (2.33 vs 1.27, 
p=0.028), conduct problems (3.50 vs. 1.27, p=0.003), hyperactivity-inattention (8.17 vs. 2.60, 
p<0.001) and impact score (3 vs 0, p<0.001), and lower on prosocial behavior (7.67 vs. 8.93, 
p=0.012) Teachers scored x-linked significantly higher on hyperactivity-inattention (7.5 vs. 
2.71, p=0.035), peer problems (1.83 vs. 0.43, p=0.022) and impact score (3.40 vs. 0.17, 
p=0.033), and lower on prosocial behavior (4.5 vs. 8.29, p=0.022). Seven of the children attend 
mainstream school, two go to special units and one attends a deaf preschool.  
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DISCUSSION 
 
This thesis discusses aspects of cochlear implantation in two specific groups of patients. Both 
groups, patients with partial deafness and pediatric cochlear implant candidates with a 
malformed inner ear, constitutes an increasing part of the patient population at the Cochlear 
Implant Clinic at Karolinska University Hospital. For both patient categories individualized 
treatment is of vital importance for the outcome. Every cochlear implant candidate should 
expect a treatment with a combination of an intervention with minimal surgical trauma and a 
maximum of benefit in relation to each individual’s condition and cause of hearing loss. For 
the two groups in this thesis this is clearly visible. Individualized follow-up in a team of 
experienced audiologists and engineers as well as trained speech-and language pathologists 
and social workers is also essential for both patient categories.  
HEARING PRESERVATION DURING COCHLEAR IMPLANTATION 
The surgical technique for hearing preservation in a cochlear implantation procedure is 
standardized, not differing much from a routine CI case, and described by several authors 
(Lenarz et al., 2006, Lorens et al., 2008, Van Abel et al., 2015). A transmastoid-facial recess 
approach, taking care not to drill on the head of the incus or manipulate the ossicular chain, is 
used. Opening of the cochlea may be performed by a cochleostomy, carefully drilling to 
visualize the endosteum but not entering the scala tympani. However, a RW approach is 
preferred by most surgeons. For this, the RW bony niche is removed in order to visualize the 
RW membrane. At this point, the middle ear is rinsed and corticosteroids applied on the RW 
membrane or the endosteum. The choice of steroid has differed, but often Triamcinolone is 
used. Some surgeons prefer to give one dose of iv steroid, often Hydrocortisone or 
Betamethasone, prior to opening the cochlea. An incision is made in the RW membrane or 
endosteum and a thin and flexible electrode array slowly inserted. Straight arrays are preferred 
by most authors, and have shown good hearing preservation results. Care is taken to stabilize 
the electrode and avoid suctioning near the opening of the cochlea. The seal of the cochlea is 
softly applied and not packed around the array. In addition to the corticosteroids given during 
the procedure, some authors recommend one week of oral methylprednisolone or prednisolone. 
Paper I demonstrates that deep insertion (4.5 mm, group 2), with the associated large trauma, 
results in a substantial threshold shift, concluding that the insertion in this case alone is 
responsible for the permanent hearing loss. This most likely happens because rupture of the 
basilar membrane leads to a loss of cochlear potentials. In hearing preservation cases a deeper 
insertion than 360° is not likely to be beneficial, even though there have been reports showing 
residual hearing preservation with longer electrodes (Tamir et al., 2012, Nordfalk et al., 2016). 
The benefit of corticosteroids for hearing preservation has been demonstrated in animal studies 
(Chang et al., 2009, Maini et al., 2009, Connolly et al., 2011, Lee et al., 2013). There are also 
indications that an extended delivery of steroids, as with the postoperative regime in humans, 
may benefit hearing preservation (Rah et al., 2016). Clinical studies regarding possible benefits 
of steroid treatment are underway (Enticott et al., 2011). 
Several authors have demonstrated that hearing preservation can be achieved. This is clearly 
desirable, as there is evidence that a combined electrical and acoustic stimulation is beneficial, 
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improving hearing, especially speech in noise (Gstoettner et al., 2009, Kong et al., 2015), and 
gives improved quality of sound and music (Brockmeier et al., 2010). In a meta-analysis of 24 
studies Santa Maria and co-authors concluded that cochleostomy was associated with better 
hearing preservation as compared to the round window approach. Also a slow electrode array 
insertion technique was superior to insertion of less than 30 seconds and the use of 
postoperative systemic steroids (Santa Maria et al., 2014).  
However, most studies examine short term results. Long term clinical studies reveal a trend of 
slow and continuous hearing loss. This may relate to the pathology of the individual reason for 
hearing loss, thus, the patient did not have a stable hearing loss prior to surgery, but is in most 
cases likely to depend on an intracochlear process leading to hearing deterioration. The nine 
subjects Mertens and colleagues (Mertens et al., 2014) followed for up to eleven years a gradual 
loss was seen for most of them. Erixon and co-workers (Erixon et al., 2015) followed 19 
patients for up to three years, displaying a gradual low frequency loss and recently Helbig et 
al. reported on a large number of patients (n=96) that were followed up to eleven years (Helbig 
et al., 2016). Here a similar pattern of gradual loss is seen, however with large individual 
variability. The loss seen exceeds that of the contralateral ear and these studies clearly show 
that there is an ongoing intracochlear process that must be explained by the implantation itself.  
LOSS OF RESIDUAL HEARING AFTER COCHLEAR IMPLANTATION 
The most important finding in paper I is that there is no statistical difference (p=0.13) between 
performing a cochleostomy (group 1) compared to combining this with a moderate insertion 
(group 3). From this perspective, the electrode insertion itself does not explain the alterations 
in hearing seen in the early postoperative period. In guinea pig cochlear implantation, other 
authors have used insertion depths ranging from 2.25-3.25 mm (Braun et al., 2011, Connolly 
et al., 2011, Quesnel et al., 2011). For these moderate, less traumatic, insertion depths the 
authors have been able to preserve hearing, often in combination with corticosteroid treatments.  
 
Histopathology of patients with a CI reveals damage to intracochlear structures like the spiral 
ligament, stria vascularis and hair cells in most implanted ears (Fayad et al., 2006). In a human 
cochlea it is shown that the force necessary for insertion increases beyond 20 mm, when a 
straight electrode is used (Adunka et al., 2006). Therefore, a moderate, less traumatic, insertion 
in a human cochlea could be approximated to 20 mm, corresponding to a distance near 360° in 
most cochleae. However, this varies since the length of the basal turn lateral wall ranges from 
20.7 to 24.2 mm (mean 22.8 mm; (Erixon et al., 2009). Very shallow insertion (8 mm), with a 
lesser cochlear coverage, leads to worse speech perception results (Buchman et al., 2014). An 
insertion of 20 mm insertion is shown to give an adequate auditory outcome in a study by 
Adunka and colleagues in 2010 (Adunka et al., 2010). Here they could demonstrate that a 20 
mm electrode (where the tip approximately reaches the region of 1000 Hz on the organ of 
Corti) gives speech perception performance comparable to a longer electrode (31.5 mm).  
 
As there is controversy regarding the possible benefits of deep insertion (Boyd, 2011) one could 
argue that a 360° insertion should be attempted in all cases of implantation as it will give a 
reasonably good auditory outcome while minimizing trauma. Minimizing intracochlear 
damage is important for future cochlear implant revision surgery or other, today unknown, 
alternative intracochlear treatments. On the other hand, there are indications that a deeper 
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insertion is beneficial to improve speech understanding in noise as well as the perceived sound 
quality (Hochmair et al., 2015). In cases of hearing preservation this is not an issue as the apical 
region is functioning with residual low frequency hearing and it is therefore not necessary to 
attempt to stimulate this region in any case. 
Possible explanations for short- and long term permanent hearing loss have included a direct 
effect of the inserted electrode, structural changes and inflammation. Induction of pathways 
leading to apoptosis has also been suggested (Eshraghi et al., 2006). The effects of a direct 
trauma, such as perforation of the basilar membrane, and leakage of fluids between 
compartments is an obvious acute reason for permanent hearing loss. Additional direct effects 
could come from the electrode volume itself creating altered cochlear michromechanical 
properties, leading to an “cochlear conductive component” (Banakis Hartl et al., 2016). The 
electrode may also interfere directly with surrounding structures in scala tymapni and thereby 
affect the production, and absorption, of cochlear fluids. Further, inflammation caused by the 
surgical trauma and the presence of a foreign body has been suggested as mechanism for 
gradual sensorineural hearing loss. The inflammation may influence ion regulation and water 
permeability, possibly by altering vascular permeability in stria vasculris. This likely 
inflammatory process is the rationale for the use of corticosteroids. The inflammation may also 
induce development of soft tissues around the electrode array seen as fibrosis in 
histopathological examination. 
In addition to structural damage, histopathological studies of human temporal bones have 
indicated presence of endolymphatic hydrops in patients with a cochlear implant (Handzel et 
al., 2006, Richard et al., 2012). Similar finding have been made in guinea pigs at three months 
following cochlear implantation (Lee et al., 2013). Paper II tested the hypothesis that cochlear 
implantation may induce endolymphatic hydrops and that this could explain the gradual 
hearing loss seen in patients with residual hearing. The rationale for this was that long-term, 
fluctuating, endolymphatic hydrops is associated with permanent sensorineural hearing loss in 
combination with the finding of hydrops in cochleae with a cochlear implant. In addition, it is 
well known that patients may experience dizziness after cochlear implantation. The results 
show that hydrops is present during the first week after cochlear implantation but not later in 
the test period (28 and 72 days). Possibly this finding could explain the temporary threshold 
shifts seen in paper I with a large shift in ABR thresholds immediately after cochleostomy or a 
moderate implantation followed by a gradual normalization. A pattern that resemble the CAP 
threshold shifts in paper II. 
MALFORMATIONS OF THE INNER EAR 
During the last decades the knowledge of inner ear malformations have broadened, much 
related to better imaging techniques. As both CT and MRI today provide pictures with better 
resolution, more details may be revealed. The Jackler classification from 1987 was based on 
the polytomography technique with limitations in resolution (Jackler et al., 1987). With 
increasing interest in cochlear malformations related to growth of pediatric cochlear 
implantation programs, Sennaroğlu and Saatci suggested a new classification in 2002 with the 
main contribution of further subclassifying the incomplete partition as type 1 and type 2 
(Sennaroglu et al., 2002). In 2006 the classification was extended with incomplete partition 
type 3 (Sennaroglu et al., 2006) and is today widely accepted. In short this classification today 
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include Michel aplasia and cochlear aplasia, quite rare types, which both entail complete 
absence of the cochlea. Additional severe malformations include cystic vestibulo-cochlear 
malformations such as common cavity and incomplete partition type1 (IP-1) and incomplete 
partition type 3 (IP-3). The most common malformation is the less severe incomplete partition 
type 2 (IP-2), with a well-shaped basal part and a moderate modiolar dysplasia including a 
defective apical region. The severity of cochlear hypoplasia (CH, cochlea less than normal 
size) malformations varies. Sennaroğlu subclassifies these into four groups, CH type 1 with a 
cystic budlike appearance, CH type 2 with a more normal external shape but still cystic or 
limited modiolar development, CH type 3 where the cochlear duct is shorter than normal but 
with otherwise well-organized intracochlear structures and CH type 4 with normal basal turn 
but dysplasic apex. Phelps (Phelps, 1992), Zheng and colleagues (Zheng et al., 2002), Papsin 
(Papsin, 2005) and Giesemann and co-workers (Giesemann et al., 2011) and have all suggested 
minor alterations in this classification. 
 
In addition to cochlear malformation, the deformities of the vestibular part of the inner ear, the 
vestibule and semicircular canals (SCC), varies greatly from severe cystic malformations to 
mild SCC deviations. SCC dysplasia seem to be more common with hypoplastic cochlea 
malformations, as in cases with narrow IAC. The vestibular aqueduct may be enlarged (LVA) 
whereas the cochlear aqueduct seems to be very consistent. Theoretically a wide cochlear 
aqueduct, which establish a communication between the intracochlear perilymphatic space and 
the subarachnoid space, could give a gusher during surgery but this has never been encountered 
in the author’s experience. LVA may exist alone or, as it often is, together with IP-2. It is very 
likely that with better future imaging resolution additional minor modiolar dysplasia will be 
discovered in the cases of LVA that today appear to have a normal cochlea 
 
The possibility for histological examination of malformed human cochleae is limited. In a 
recent work, Sennaroğlu reports on the examination of 33 specimens in the collection of the 
Otopathology Laboratory at Harvard University's Massachusetts Eye and Ear Infirmary 
(Sennaroglu, 2016). They displayed a variety of inner ear malformations and he compared the 
results with CT and MRI images. He suggests that for cochlear hypoplasia the membranous 
labyrinth development determines the size of the bony cochlea. For severe internal architecture 
deformities, like in IP-1 and severe hypoplasia (CH-1 and CH-2), a deranged vascular supply 
from the internal auditory canal is the major contributing factor. For IP-2 an enlarged 
endolymphatic sac (with LVA) is likely to be responsible for the modiolar dysplasia related to 
high intracochlear endolymphatic pressure. There was no specimen with an IP-3 malformation 
in the collection but the author suggests that the thick inner endosteal layer of the otic capsule 
forms the abnormal shape, when related to the thin or absent middle endochondral and outer 
periosteal layers of the surrounding bone. In IP-3 the organization of the membranous labyrinth 
and spiral ganglion neurons remains unclear as the modiolus is completely absent. As the 
cribriform base of the cochlea is missing there is an open connection to the CSF space.  
 
Jackler (Jackler et al., 1987) suggested a developmental arrest theory for the different 
malformations. Interruption during inner ear embryogenesis were to result in the different 
cochlear dysplasia’s seen, most of them around the sixth gestational week. The cochlear duct 
develops during a remarkably short period, only sixteen days from a cochlear pouch to its full 
length (Streeter, 1949). For cochlear aplasia a developmental arrest may explain the 
morphology but for other types, the linear Jackler arrest theory has to be regarded with some 
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skepticism. With the existing knowledge from CT and MRI in combination with the above 
described histopathological findings it is more likely a multi-factorial course of events after the 
cochlear bud development. It is likely that multiple, independent, arrests may occur for the 
differences in development of size itself and internal structures. These paths do not seem strictly 
related as all types of combinations may be seen. The work by Papsin 2005 suggested a 
classification of cochleovestibular anomalies based on independent arrests of development. 
 
Known genetic factors causing inner ear malformations are POU3F4 mutation in x-linked 
malformation and SLC26A4, encoding for the Pendrin protein (Pendred syndrome) with the 
associated IP-2 malformation. There is likely to be other, today unknown, gene mutations or 
combinations of these, responsible for the other types of malformations we see. Although 
genetics is likely to be the primary reason for anomalous development, environmental factors, 
such as for instance viral agents, may also play a part. The fact that a malformation may be 
unilateral or that a patient may have malformations of different severity on either side indicate 
multifactorial etiologies.  
 
Classification of a condition is important for several reasons. The subtypes may be studied 
relating to challenges during surgery, identifying pit falls, thereby ensuring that the surgeon is 
properly prepared, minimizing risks for complications. Furthermore, by dividing cases into 
groups, the outcomes may be discussed in relation to specific malformations, which gives a 
possibility to identify special needs for follow-up and training. For anyone who sees many 
children with different cochlear malformations in clinic, it is obvious that patients differ greatly 
in audiological outcome and spoken language performance. 
 
In our material of bony cochlear malformations we currently have 4% IP-1, 60% IP-2 and 15% 
with IP-3. In addition 21% of the cases have hypoplastic cochleae. The proportion of IP-3 is 
high compared to other data (Papsin, 2005, Sennaroglu, 2010). As described earlier, this 
malformation has a cork screw appearance of the cochlea, modiolar aplasia, absent cribriform 
bone in the fundus, and a wide internal auditory canal. The children in study III and IV have 
this type of malformation. The fact that these children have residual hearing indicate that there 
is some organization of the organ of Corti in spite the complete absence of the modiolus. The 
functioning hair cells have to be structured in a way where they still are susceptible to sound-
evoked vibrations, and there has to be an intact endolymphatic space as well as a reasonable 
cochlear potential (normally a positive potential of 80-100mV). Further the spiral ganglion 
neurons have to be organized with the dendrites connected to the inner hair cells. Figure 3, page 
7, shows bone-conduction thresholds ranging from less than 30 dB at 250 Hz, dropping to 65dB 
at 1 kHz and above. Air conduction thresholds confirm a very large air-bone gap (ABG). 
Hypothetically several factors can explain this ABG. A true conductive portion of the hearing 
loss such as stapes fixation is likely to play a role. In the author’s experience, stapes fixation is 
often found in these patients during cochlear implant surgery, but improvements in mobility 
have been described once the high intracochlear pressure is relieved by opening the cochlea, 
hence, no true structural fixation would exist. Further, the fact that the membranous labyrinth 
to some extent has to be floating loosely, as the bony modiolar structures are missing, must 
radically change the mechanical properties of the organ of Corti. The shape of the audiogram 
in these patients show that the low-frequency regions of the organ of Corti retains more 
function. This may indicate a loss of the normal stiffness gradient of the basilar membrane (von 
Békésy, 1960). Other hypothetical reasons include non-functioning outer hair cells, which 
  35 
would be consistent with a loss near 60 dB, or a high intracochlear pressure that interferes with 
the micromechanical properties of the organ of Corti. It has also been considered an option that 
the IP-3 has a false ABG related to an “inner ear conductive hearing loss” (Snik et al., 1995). 
Further, if the opening to the IAC acts as a third window, the bone thresholds could be falsely 
elevated as the cranial cavity would be “acting as an amplifier” for bone-conducted sounds 
(Minor, 2003).  
SURGERY TO THE MALFORMED COCHLEA 
Early intervention is the aim for all treatment of congenital hearing loss. Neonatal screening is 
today a routine procedure in all developed countries, often with otoacoustic emissions. Further 
investigation includes ABR and ASSR. When hearing loss is found, the child is fitted with 
hearing aids at the earliest age possible. In severe-profound deafness, a MRI is performed, 
thereby visualizing the inner ear anatomy and auditory nerves. To administer this in the first 
four-five months of life, a strict routine needs to be followed. 
With signs of inner ear malformation, a CT is performed to better visualize the bony labyrinth. 
The malformation may then be classified and additional treatment planned. For the very rare 
malformations where the inner ear (Michel aplasia) or cochlea (cochlear aplasia) is absent, a 
cochlear implant isn’t a treatment option. These children should be considered for an auditory 
brainstem implant (ABI) for direct stimulation of the cochlear nucleus (Sennaroglu et al., 
2016). This may also be considered in case of common cavity or very severe hypoplasia, 
although a CI usually is considered a primary treatment option. The same argument may be 
used on auditory nerve aplasia. In a true nerve aplasia, a CI is obviously not a treatment 
alternative but an ABI is performed. However, cases with no sign of auditory nerve on MRI 
may still respond to electrical ABR (eABR) and electrical stimulation if implanted with a CI 
(Acker, 2001). This indicates that 3 Tesla MRI resolution is not sufficient to visualize the most 
pronounced nerve hypoplasia cases. For this reason, a CI, at least if preceded by positive eABR 
result, is possibly a better treatment option than an ABI, especially in view of the risks inherent 
in manipulating and stimulating the brainstem.  
Although early surgery, today often between five-nine months of age, is the routine for 
pediatric cochlear implantation the finding of a malformation usually delays the intervention. 
This is often related to referral to a tertiary hospital. In the studies in this thesis, the average age 
of implantation was 1.8 years in the x-linked group (range=0.9-2.8 years, control group average 
age 1.9 years, range=0.7-5.5 years). In Sweden, the Karolinska University Hospital is 
responsible for the assessment, cochlear implantation procedure, and first year follow-up of all 
children with temporal bone malformations. An average of our material over the last five years 
reveals that 21% of the pediatric cochlear implant recipients have some kind of abnormality to 
the temporal bone. 
Several authors have addressed the challenges related to cochlear implantation of a malformed 
cochlea (Papsin, 2005, Sennaroglu, 2010). The transmastoid-facial recess approach can be used 
in the large majority of malformation cases. When this is not possible it is usually related to a 
deviant route of the facial nerve. A standard approach was used in all 15 cases of cochlear 
implantation in the children with IP-3 in paper III and IV and no abnormalities of the facial 
nerve were encountered. As expected, a gusher occurred on opening of the cochlea in all cases. 
This is a very consistent finding in all reports on IP-3 surgeries. More often, a slow perilymph 
leak, oozing, may be found. This is seen in several conditions, such as IP-2 and some, but not 
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all, hypoplastic cochleae. The overall rate of gusher and oozing varies widely. Papsin (2005) 
reports 6.7% (n=103) CSF outflow and Sennaroğlu (2010) 30% (n=71). 
With the opportunity to perform cochlear implantation in all children with a temporal bone 
malformation at Karolinska University Hospital follows a responsibility to report our results 
from this group of pediatric recipients. This is a unique opportunity to gather information from 
a national perspective and scrutinize each malformation subtype. By chance, Karolinska has 
seen unusually many children with POU3F4 related inner ear malformation, IP-3, even 
compared to cochlear implant centers in larger countries.  
COCHLEAR IMPLANT TREATMENT OF POU3F4 DEAFNESS 
In 1968, Olson and co-workers described a case of CSF leak and stapes fixation (Olson et al., 
1968). This was followed by a report in 1971 by Nance and colleagues describing a progressive 
mixed hearing loss in males (Nance et al., 1971) where the conductive component of the 
hearing impairment was caused by stapes fixation. Attempting stapes surgery in these patients 
resulted in a perilymphatic gusher. The syndrome was described as Nance deafness or 
Perilymphatic gusher-deafness syndrome and was recognized to be inherited in an x-linked 
manner. In addition to the often rapidly progressive hearing loss, these patients exhibited a 
reduced vestibular response. Later, anatomical dissections discovered a wide internal auditory 
canal, and this was verified with polytomography (Cremers et al., 1985) and CT (Phelps et al., 
1991). This also discovered the absence of bony cribriform plate between the internal auditory 
canal and the basal turn of the cochlea. As described earlier, de Kok and colleagues in 1995 
identified the gene on the X-chromosome, POU3F4, responsible for the malformation. 
 
With the experience of gusher and deterioration of hearing related to stapes intervention, 
hearing aids were the recommended therapy at the time. Using a BAHA has been considered 
but there is no attempt reported. Case reports of this condition, review male children with 
moderate-severe mixed hearing loss and attempts for stapes surgery resulting in a CSF gusher. 
An increase in sensorineural component (worsening bone conduction thresholds) is seen in the 
postoperative period. The children were fitted with conventional hearing aids, however with 
poor auditory outcome, and they usually entered deaf schools, at the best aiming for total 
communication (Carlson and Reeh 1993).  
 
Cochlear implantation was regarded as contraindicated because of the severity of malformation 
of the modiolus and fundus of the IAC (Phelps, 1992).  There were obvious concerns related 
to the management of the gusher and the possibility of postoperative rhinorrhea, as well as the 
risk of electrode displacement to the IAC. In 2006, Sennaroğlu and colleagues reported 
cochlear implantation in one child with x-linked deafness (Sennaroglu et al., 2006). Describing 
this as a feasible method, and also adding the malformation to their classification system, it 
opened up CI treatment in this category of children. They described a 20-minute CSF gusher 
and insertion of a short straight electrode. Rhinorrhea occurred at day three requiring the 
placement of a lumbar drain for four days. In 2007 the first child with x-linked malformation 
received a cochlear implant at Karolinska. The boy was 1.6 years old and received a MED-EL 
Pulsar device to his right ear. A round window approach was used. A first insertion with a test 
electrode revealed IAC positioning on intraoperative x-ray but a straight Medium (24 mm) 
electrode was successfully placed within the cochlea, the position confirmed by conventional 
x-ray. At day two the boy experienced rhinorrhea, however gradually decreasing during six 
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days of conservative treatment and a lumbar drain was not used. During the following eight 
years ten children have received cochlear implants, five of them bilateral in a sequential 
procedure.  
 
Other implant centers have reported cochlear implantation in children with x-linked deafness. 
In the years after Sennaroğlu’s initial report (Sennaroglu et al., 2006) four groups described 
their experience (Incesulu et al., 2008, Aschendorff et al., 2009, Lee et al., 2009, Stankovic et 
al., 2010). These groups describe difficulties during implantation, with IAC dislocation of the 
electrode array and different methods for CSF leak management. Incesulu et al. (2008) reported 
on four patients that were implanted with perimodiolar electrodes without lumbar drain. One 
of the patients required re-operation shortly after the initial procedure as the electrode had been 
inserted into the IAC. Two complications were reported, one patient developed facial nerve 
stimulation after five years requiring a replacement implant and a second developed a device 
failure after four years and received a new implant on the contralateral side. Aschendorff and 
colleagues (2009) describe an implantation in an adult case with radiological assistance during 
implantation to verify the array position of a perimodiolar electrode. Lee et al. (2009) reported 
on three patients implanted with straight arrays. All patients were successfully implanted and 
they describe an uneventful post-operative period and audiometric responses were obtained at 
loading four weeks after implantation. Intra-operative management was not discussed. 
Furthermore, Stankovic and co-workers (2010) reported four patients implanted and followed 
for a period of 2 to 6 years. They were implanted with straight arrays and had lumbar drains 
inserted before cochleostomy. The CSF gusher was controlled with placement of a lumbar 
drain lowered to 10-15cm below the external auditory meatus. In spite this, one patient required 
revision surgery for rhinorrhea at day seven and another at one year. In 2013 Kang and 
colleagues reported four children, two implanted with straight electrodes and two with 
perimodiolar. One case required revision surgery due to electrode insertion into the IAC and 
postoperative CSF leak.  
 
During the last year an additional four groups have reported on cochlear implantation in 
children with x-linked malformation (Cosetti et al., 2015, Choi et al., 2016, Kim et al., 2016, 
Saeed et al., 2016). Cosetti et al. (2015) described five cases whereof two were revisions. They 
used a fluoroscopy technique with multiple exposures during implantation and also 
recommended an oval-shaped cochleostomy to better control the array during implantation. 
Choi and co-workers (2016) studied 11 subjects with POU3F4 verified mutation and implanted 
eight of them (three only presented with a moderate hearing loss). Their results indicated that 
auditory outcome is worse compared to age-matched controls implanted without inner ear 
malformation. No link was seen between type of mutation and initial auditory performance. In 
an attempt to compare mutation type (genotype) to postoperative outcome (phenotype) 
possibly those with a truncation or deletion performed worse. Kim and colleagues (2016) 
reported on bilateral sequential implantation on one child only without complications and 
Saeed et al. (2016) described bilateral implantation in two children. Postoperative CSF leak as 
rhinorrhea or fluctuant postauricular swelling complicated the procedure in all cases leading to 
a recommendation of obliteration of the Eustachian tube and middle ear in all cases. 
 
The results of our procedures are reported in paper III, concluding that cochlear implantation 
in x-linked malformation cases is a safe procedure. The gusher should be waited out as it ceases 
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after approximately 15 minutes and attempts of electrode insertion prior to that is likely to 
increase the risk of IAC placement. The seal around the electrode at the opening to the cochlea 
has to be meticulously packed with circumferential soft tissue to avoid postoperative CSF leak, 
presenting as rhinorrhea. In our experience, there is no need for a lumbar drain. Only one case 
in paper III had postoperative rhinorrhea, starting at day two. Our management at the time was 
conservative. Although this was successful, the presently recommended management strategy 
for postoperative CSF leak in cases with x-linked malformations is a revision procedure and 
renewed packing with soft tissues. Sealing by additional surgical obliteration of the middle ear 
space or by a subtotal petrosectomy and blind end closure of the external auditory canal should 
be regarded as a salvage procedure only. 
 
Of the 40 cases of primary pediatric cochlear implantation described in the studies above, a 
straight electrode was used in 25, uni- or bilaterally. There is no obvious correlation between 
the electrode type and the complication rate. However, theoretically, a precurved electrode 
could cause more damage if it were inserted in the IAC and then withdrawn, having curled 
around neural structures or the membranous labyrinth. It must be stressed that intraoperative 
imaging is mandatory, as there is a high risk of IAC displacement of the electrode, 20% (3/15) 
in our experience. Failure to recognize this will not only lead to absent post-operative speech 
understanding but also to a risk of facial nerve stimulation (Cosetti et al., 2015). Simultaneous 
bilateral implantation is described in one child (Cosetti et al., 2015), however, in the author’s 
opinion this is not to recommend since the side in need for a revision surgery will not be known, 
in case a postoperative rhinorrhea develops. 
 
In the eleven studies above, including paper III, cochlear implantation is described in two 
female children only, one in Incesulus report and one in paper III. Naturally, x-linked deafness 
is predominantly seen in males. Incesulu et al. (Incesulu et al., 2008) questioned if true IP-3 
malformations really can occur in females and attributed their origin to other reasons. However, 
genetic analysis was not performed in this study, and Marlin and co-workers (Marlin et al., 
2009) described eight females with verified POU3F4 mutations, one of them with a typical IP-
3. The same applies to the subject in paper III, with a large heterozygous POU3F4 deletion and 
a typical IP-3 appearance of the malformation. Possibly this could be explained by skewed X-
chromosome inactivation (Minks et al., 2008). In 1998, Papadaki and colleagues (Papadaki et 
al., 1998) reported on two sisters with severe mixed hearing loss and temporal bone imaging 
consistent with IP-3, although genetic testing was not performed. A moderate hearing loss 
could be seen in two of the seven female POU3F4-carriers with normal temporal bones in 
Marlin’s study (Marlin et al., 2009). The same type of hearing loss was seen in the three male 
subjects in Choi’s study (Choi et al., 2016), none of whom received a CI. This confirms that 
POU3F4 mutations and IP-3 malformations do not necessarily lead to a severe-profound 
hearing loss even in male subjects. Apparently the phenotype varies, and as patients with a 
moderate hearing loss often neither is subject to genetic testing or temporal bone imaging, the 
true prevalence of x-linked malformation is unknown. 
HEARING WITH A COCHLEAR IMPLANT AND X-LINKED MALFORMATION 
The majority of the studies cited above focus on the surgical procedure and complications. 
Although most of them also report auditory outcomes, the follow-up time is often short and the 
performance measures are limited, only stating the occurrence of response to an auditory 
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stimulus or hearing thresholds with the CI. Lee et al. (Lee et al., 2009) report good outcomes 
in two children, who achieved open-set word performance of 96 and 64%, and one child with 
minimal speech but improvement in sound detection (although mental retardation may have 
complicated assessment in this case). On the contrary, Stankovic (Stankovic et al., 2010) 
discuss four patients (age at implantation between 1.1-3.7 years) where auditory perception 
post-implantation had not progressed past sound or single word detection. One patient achieved 
better speech perception but only due to contralateral amplification with a hearing aid. Cosetti 
(Cosetti et al., 2015) describe three children with at least one year follow-up and suggests that 
good auditory performance may be achieved in x-linked malformation, since these patients 
were able to perform open-set multisyllabic word recognition. Kang and colleagues (Kang et 
al., 2013) followed three patients for 1.5-6.4 years and reported on good auditory outcome, 
with no difference when comparing performance with age-matched patients with normal 
cochleae. This result was obtained by using scores from the Meaningful Auditory Integration 
Scale (MAIS) and Categories of Auditory Performance. However, these scales are based on 
estimations by parents or audiologists and not on objective testing. Finally, Choi (Choi et al., 
2016) reported on eight patients with a two year follow-up, finding a significant difference in 
CAP scores at two years compared with age-matched controls without inner ear malformation 
(p<0.05). Both paper III, comparing audiological outcome with a mean of pediatric recipients 
of a national two-center study and paper IV, comparing to a control group, shows significantly 
lower performance in speech perception, both in quiet and in noise, in spite of normal hearing 
thresholds with CI. No statistical difference was seen in sound localization. There seems to be 
some variability in outcome, but given the data of these previous studies and the papers in this 
thesis, in total, the concluding trend must be that children with x-linked malformation performs 
worse in functional auditory outcome although good hearing thresholds with a CI may be 
obtained. This indicates poorer sound processing in the x-linked group and may be linked to 
limited spectral and/or temporal resolution related to intracochlear issues, such as an abnormal 
spiral ganglion neuron organization. It may also be related to inferior nerve signal transmission 
capacity or an altered ability of central sound processing. 
X-LINKED MALFORMATION, POSSIBLY A SYNDROMIC HEARING LOSS 
Today, POU3F4 related x-linked malformation is regarded as a non-syndromic hearing loss. 
In the studies above only a few authors mention symptoms or findings other than hearing loss, 
such as the children’s behavior, on assessment and follow-up. 
 
It has previously been reported that children with x-linked deafness exhibit features including 
testing difficulties. Stankovic suspected cognitive and developmental delays associated to the 
hearing loss. They go on to suggest that the developmental delay and loss of hearing could be 
associated through the malfunctioning of POU3F4. Choi, on the other hand, stated that no 
syndromic feature was seen during the two year follow-up. Reviewing the literature on x-linked 
malformation or POU3F4, there are occasional reports describing behavioral features of these 
patients. (Carlson et al., 1993) reviewed three children with x-linked deafness and hearing aids. 
On describing the children they state that “KM continues to demonstrate severe developmental 
delays in speech-language, visual-motor integration, and fine motor skills. These difficulties 
contribute to his persistent insecurity and apprehension in the test situation.”. Regarding his 
half-brother, the same authors summarize “MB was diagnosed as having attention deficit 
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disorder in 1988 and subsequently placed on Ritalin for his hyperactivity. He continues to be 
followed in the child development clinic for his behavioral and speech/language difficulties.”.  
 
Our clinical experience during a relatively long follow-up revealed a group of children with 
complex needs. In paper IV older children (>4 years, n=6) with POU3F4 verified x-linked 
malformation hearing loss are examined, and the results indicate that they exhibit difficulties 
not only in the domains of hearing but also language, and some subdomains of cognition and 
mental health, compared with a hearing-matched group. These findings correlate well with 
reports, as with the example above, stating neurodevelopmental difficulties. Four of the older 
boys in paper IV received an ADHD diagnosis. The cognitive performance of the x-linked 
group could be related to alterations in central function during embryogenesis. Controlling 
early development, linked to the development of the neural tube, in mice the gene pou3f4 has 
a regulatory role which is not fully clarified. As it is expressed in periotic bone during 
labyrinthine development as well as brain structures, including frontal lobes, it is likely to have 
a role in early stages of embryogenesis in both areas. Pou3f4 mutations are known from animal 
studies to lead to inner ear malformations (Phippard et al., 1998, Minowa et al., 1999), 
however, to the author’s knowledge, there are no behavioral studies on mice to support a 
neurodevelopmental disorder. 
 
To conclude, based on our present knowledge of POU3F4 in human and animal studies, 
previous indications of altered behavior, cases of confirmed ADHD and the findings in paper 
IV it seems unlikely that the hearing loss alone explains the features demonstrated by paper IV. 
X-linked hearing loss is today classified as a non-syndromic genetic hearing loss related to 
mutations in the POU3F4 gene or surrounding domain. However, the correlation between type 
of malformation, similar genetic findings and consistent behavior in our study group indicates 
that this type of hearing loss may be part of a syndrome including hearing loss and 
neurodevelopmental disorder consistent with hyperactivity and attention deficit.  
FUTURE PERSPECTIVES 
The cochlear implant is the worlds most developed bionic device and has opened the field of 
electrical intervention. The knowledge obtained from this system of electrical stimulation will 
be useful in other areas. The concept of sensory electrical stimulation is today expanded to 
vestibular or ocular implants, currently in clinical trials. Other areas using electrical stimulation 
include deep brain stimulation. Although there are attempts at using infrared laser light for 
neural activation (Fridberger et al., 2006, Tan et al., 2015), electricity is likely to continue to 
be the main mediator due to its relative simplicity and the substantial clinical experience that 
has been accumulated. Efforts should continue in the direction of improving the neural 
interface, in a cochlear implant the intracochlear electrode array. Several attempts are currently 
made for improving the properties of the electrode, for instance by including slow release 
mechanisms for intracochlear medication and less traumatic electrode properties. Both are 
import for strategies for improving hearing preservation. The concept of minimizing trauma 
during surgery is also important for ease of future revision surgery and optimizing the 
possibilities of alternative treatments. 
 
The use of cochlear implants has expanded to new patient categories. It is no longer a device 
for profoundly deaf patients only. The indications have evolved over the last decades including 
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the domains of this thesis, patients with residual hearing and children with malformed cochleae. 
Both groups of patients were previously judged as unsuitable candidates but efforts by a large 
number of research groups have shown that cochlear implantation not only is possible but also 
an intervention with good outcome. 
 
Today, it is possible to preserve residual hearing in most patients receiving cochlear implants. 
One of the most important remaining questions is how to maintain results. Further work is 
necessary to understand the mechanisms that are involved in cases of late loss of hearing after 
implantation, as well as possible direct treatments. The area of drug delivery to the inner ear 
has only started. 
 
With increasingly better resolution on CT and MRI, the work on classifications of the 
malformations must continue. In addition, for the unusual malformation IP-3, histopathological 
studies will be essential to understand the organization of the membranous labyrinth and SGN. 
This may reveal precise explanations to the conductive component of the hearing loss as well 
as to the poorer audiological outcome on electrical stimulation. For all malformations genetic 
analysis is likely to be increasingly important. In cases of malformations, bony as well as 
membranous, it is necessary to clarify the regulatory roles of the genes involved in 
embryogenesis. Today these are not sufficiently known to explain the diversity of phenotypes 
expressed. Combining the domains of imaging, histopathology and genetics will be the most 
successful way forward in understanding the mechanisms involved in the subtypes of temporal 
bone malformation. There is also a need for increased knowledge in the complex system of 
auditory pathways, from the cochlea to a subcortical and cortical level, to comprehend how we 
learn to hear. 
 
Evaluating the malformation subtype IP-3 as in this thesis is one step forward. Every category 
of malformations should be analyzed, identifying the specific difficulties for that group. A 
difficulty in this lies in the small number of children examined at each center, and that the 
possibility of long term follow-up may be limited. To centralize the malformations of a country 
to one center, as in Sweden, is a first step but future work should include international 
collaboration. As a first step for this to be successful a consensus of comparable assessment 
tools is necessary. 
 
The over-all aim of the study in paper IV was to embrace a “total evaluation” of medical, 
psychological and social parameters for a comprehensive approach to the child with a cochlear 
implant. This aim, to draw the “complete picture”, is important for analysis of how to best assist 
in training the child and counsel and support the family on an individual basis. For future 
studies of groups of pediatric cochlear implantation recipients, this concept is likely to become 
increasingly important. “Good outcome” is not only about a successful surgical procedure, or 
development of speech and oral language, or socio-psychological well-being of the patient, but 
rather optimizing each area for a comprehensive good result. Understanding of, and coping 
with, the unique difficulties each individual child faces growing up with a cochlear implant is 
a key to a successful treatment. 
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CONCLUSIONS 
 
 
 
 
Paper I. The guinea pig cochlea exhibits high resilience provided the use of a surgical 
technique with limited trauma. Cochleostomy and implantation itself does not alone 
explain postoperative permanent loss of residual hearing when occuring. Very 
limited to no signs of histological changes in hair cells and spiral gangloin neurons 
are seen after short follow-up. 
 
 
Paper II. Electrocochleography and micro-CT shows that endolymphatic hydrops is present 
during the first week after cochlear implantation. The soft tissue response does not 
increase at longer follow-up.  
 
 
Paper III. Cochlear implantation is a feasible and safe alternative for hearing restoration in 
children with x-linked malformation. Complications are few and can be managed 
during the surgical procedure. With a cochlear implant the children attain hearing 
but at a lower level compared to average CI recipients and they develop spoken 
language. 
 
 
Paper IV. Children with x-linked malformation exhibit, in addition to their severe-profound 
mixed hearing loss, features of a neuro-developmental disorder in the area of 
attention deficit and hyperactivity. Their cognitive abiliteis are below those of a 
control group of pediatric CI recipients. These findings does not seem related to 
their hearing loss alone but instead to their POU3F4 mutation. This concludes a 
suggestion to re-classify POU3F4 related x-linked deafness as a syndromal hearing 
loss. 
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SAMMANFATTNING PÅ SVENSKA 
 
Hörselnedsättning är ett av de vanligaste handikappen i världen. Hörapparater är ofta en bra 
hjälp men de fungerar inte för patienter med grav hörselnedsättning eller dövhet. Möjligheten 
att använda cochleaimplantat (CI, hörselimplantat i snäckan) hos dessa patienter är ett stort 
medicinskt framsteg som revolutionerat behandlingen av svåra hörselhandikapp. Fler än fyra 
tusen vuxna och barn har opererats i Sverige under de senaste decennierna, i världen har flera 
hundra tusen opererats. 
 
Vår hörsel bygger på att ljudet som leds till innerörat kan omvandlas till nervsignaler av 
snäckans (cochleans) sinnesceller. De kallas hårceller och om de inte fungerar kan ljudet inte 
fortledas till hjärnan. Vanliga hörapparater, som förstärker ljud, kan hjälpa människor med lätta 
till måttliga hörselnedsättningar men vid uttalade besvär minskar vinsten av att förstärka ljudet, 
eftersom snäckan då saknar förmåga att skapa nervimpulser. CI innebär att man blir oberoende 
av snäckans funktion och istället stimulerar hörselnerven direkt. Under de senaste femtio åren 
har metoden för CI utvecklats successivt. I början handlade det om enkla försök med att 
stimulera hörselnerven elektriskt och på 1970-talet opererades de första patienterna. Dagens 
system är tekniskt mycket avancerade men grundprincipen är densamma, att elektriskt 
stimulera hörselnerven och på så sätt alstra nervimpulser som av hjärnan uppfattas som ett 
hörselintryck. De patienter som kan bli hjälpta med CI är dels dövfödda barn som opereras 
tidigt under barnaåren och på så sätt kan lära sig att förstå hörselintryck och därmed utveckla 
tal, dels barn eller vuxna som blivit döva och återfår hörselförmågan med CI. Tekniken i 
cochleaimplantaten utvecklas kontinuerligt för att ge bättre talförståelse, bättre möjligheter att 
uppskatta musik och vara lättare att använda. Trots att cochleaimplantat fungerar bra för 
flertalet användare finns det fortfarande områden där vi behöver lära oss mer. Den här 
avhandlingen handlar om två patientgrupper med särskilda problem. Dels de med ”partiell 
dövhet”, dels de som föds med inneröremissbildningar.  
 
Partiell dövhet 
Bland vuxna som opereras idag finns en ökande grupp med varierande grad av kvarvarande 
hörsel i basregistret (”residual hearing”). Denna hörselrest är som regel liten och patienten är 
diskantdöv med en kraftigt begränsad hörselfunktion, trots maximalt stöd av hörapparater. I 
samband med en rutinmässig CI-operation är risken stor att patienten helt eller delvis förlorar 
den kvarvarande hörseln. Orsaken till detta är oklar. Om man kan bevara patientens egen, 
naturliga, bashörsel och kombinera denna med elektrisk hörselstimulering via CI i diskanten i 
samma öra får patienten sammantaget ett bättre hörselresultat, och det blir till exempel lättare 
att höra i bullriga miljöer. En mindre traumatisk kirurgisk teknik har utvecklats 
(hörselbevarande CI-kirurgi) och denna kan kombineras med en kortare och mjukare 
implantationselektrod. Trots detta förlorar ungefär 25 % av patienterna sin kvarvarande 
bashörsel i samband med kirurgin. Avhandlingens två första delarbeten är djurexperimentella 
och handlar om att öka förståelsen av vilka sjukdomsmekanismer som bidrar till att den 
kvarvarande hörseln skadas i samband med kirurgi.  
I studie 1 bedöms hur hörseln och snäckans inre strukturer påverkas av olika grader av 
kirurgiskt trauma. Tre grupper marsvin opererades med: i grupp 1 endast cochleostomi 
(öppnandet av ett hål till snäckan), i grupp 2 utfördes en djup cochleaimplantation och i grupp 
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3 en grund cochleaimplantation. Hörseln testades med hjälp av hjärnstamsaudiometri 7, 14 
respektive 28 dagar efter operationen. Resultaten visar att marsvinets hörsel till stor del kan 
bevaras även om man borrar upp ett hål i snäckans nedersta vindling (grupp 1) liksom om man 
för in en elektrod en kort sträcka in i snäckan (grupp 3). Om man däremot för in den djupare 
förloras all hörsel (grupp 2). Försöksdjuren var normalhörande och hörseln kunde testas även 
på de höga frekvenser som låg i närheten av implantatelektroden. Mikroskopisk undersökning 
av snäckan på de marsvin som varit implanterade med en kort elektrod visade efter avslutad 
uppföljningstid, 28 dagar, att snäckans inre strukturer till stor del bevarats, hårcellernas antal 
var nära oförändrat i 3 av 5 snäckor och att nervcellernas antal var oförändrat jämfört med icke-
implanterade snäckor. Slutsatsen är att marsvinets snäcka har hög motståndskraft för måttligt 
kirurgiskt trauma och att cochleostomi eller kort implantation inte ensamt förklarar 
hörselförlust, i de fall det inträffar.  
I studie 2 undersöks hypotesen att cochleaimplantation ger så kallad endolymfatisk hydrops. 
Det innebär att man har ett övertryck i den ena av innerörats vätskor, endolymfan. Vid 
mikroskopisk undersökning av snäckor som varit cochleaimplanterade har man, hos såväl 
marsvin som människa, noterat endolymfatisk hydrops i ungefär 25 % av fallen. Hydrops, 
övertryck, har även kopplas till Menières sjukdom som ger fluktuerande yrsel, tinnitus och 
hörselnedsättning. I studien cochleaimplanterades fyra grupper av marsvin med en kort 
implantatelektrod, och djuren följdes sedan i upp till 72 dagar. Elektrocochleografi (mätning 
av elektriska svar i snäckan vid ljudstimulering) samt mikro-DT (röntgen med datortomografi) 
användes för att undersöka förekomsten av hydrops. Studien visar att det finns tecken till 
endolymfatisk hydrops under första veckan efter cochleaimplantation. 
 
Barn med missbildade inneröron 
Ungefär 20 % av de barn som opereras med CI vid Karolinska Universitetssjukhuset har ett 
missbildat inneröra. Andelen är relativt hög då Karolinska har rikssjukvård på denna 
patientkategori. Missbildningar av snäckan klassificeras övergripande i Incomplete Partition 
(ofullständig uppdelning av snäckans inre strukturer), Hypoplasia (liten snäcka) och Common 
cavity, där innerörats hörseldel (snäckan) och balansdel är sammansmält i en struktur. En 
undergrupp till Incomplete partition (IP) är typ 3 (IP3) som har en snäcka med kraftigt 
förändrad inre anatomi, där de beniga delarna i snäckans centrum och golv saknas vilket 
innebär att mjukdelarna, själva hörselorganet med hårcellerna (Cortiska organet) och 
nervstrukturerna (nervcellerna och hörselnerven) saknar sitt naturliga skelett. Dessutom 
innebär detta en stor öppning mot inre hörselgången, som i sig är vidare än vanligt, med en 
öppen kommunikation till den cerebrospinalvätska som omger hjärnan. Denna missbildning är 
kopplad till mutationer i en gen (POU3F4) på x-kromosomen. Den kallas därför ofta ”x-linked 
malformation” (x-bunden missbildning). Diagnosen sätts genom fyndet av en grav 
hörselnedsättning och den typiska inneröremissbildningen, som visualiseras med hjälp av 
datortomografi och magnetresonanskamera. Genetisk testning verifierar diagnosen. X-bunden 
missbildning klassificeras idag som en icke-syndromal hörselnedsättning, d.v.s. att den inte ger 
några andra symtom än hörselnedsättning. Avhandlingens två sista studier undersöker 
möjligheterna till, och effekterna av, cochleaimplantatbehandling på 10 barn med x-bunden 
hörselnedsättning och inneröremissbildning.  
I studie 3 utvärderas den kirurgiska metoden, dess risker och barnens språkutveckling. Studien 
visar att cochleaimplantation kan genomföras säkert, utan risk för allvarliga komplikationer, 
men att implantatelektrodens läge måste verifieras under ingreppet för att säkerställa att den 
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inte lagt sig i inre hörselgången. Med cochleaimplantat utvecklar barnen hörsel, men på en nivå 
som är lägre än genomsnittet för CI-barn utan inneröremissbildning. De lär sig talspråk och 
kan gå i vanlig skola men behöver ofta extra stöd i undervisningen.  
Studie 4 tar fasta på en klinisk erfarenhet att dessa barn, utöver hörselhandikappet, har 
uppmärksamhetssvårigheter och hyperaktivitet. Hypotesen är att mutationer i genen POU3F4 
på x-kromosomen inte bara ger inneröremissbildning med hörselnedsättning, såsom det antas 
idag, utan också ett neuropsykiatriskt funktionshinder. I denna studie jämförs de med en 
kontrollgrupp barn som har CI av annan anledning (10 barn med Connexin26 mutation). 
Resultaten av genetisk analys, fördjupad språkutredning, psykologbedömning och 
undersökning av barnens psykosociala hälsa visar att barnen har svårigheter med impuls- och 
aktivitetskontroll, uppmärksamhet och socialt samspel som inte bara kan förklaras av de 
kommunikationssvårigheter som hörselnedsättningen ger. Den samlade bilden liknar en 
ADHD-problematik, och några av de äldre barnen har fått den diagnosen verifierad. Vi föreslår 
därför att x-bunden missbildning (POU3F4 mutation) omklassificeras till en syndromal 
hörselnedsättning. 
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